US 9,670,347 B2Grant
Propylene composition with improved impact resistance at low temperature
Issue Date:2017-06-06
•19 Claims
•1 Drawing Sheets
Abstract
Polypropylene composition comprising comonomer units derived from ethylene in an amount of from 9.0 to 52.0 mol-% and comonomer units derived from a higher a-olefin in an amount of from 0.4 to 3.0 mol-%, wherein said polypropylene composition has an amount of xylene cold solubles of at least 30 wt.-%, wherein further the xylene cold soluble fraction has an ethylene content of from 20.0 to 80.0 mol-% and a higher a-olefin content from 0.1 to 1.5 mol-%.
Metadata
Assignee
- BOREALIS AG
Inventors
- Wilfried Töltsch
- Luigi Resconi
- Kristin Reichelt
Application Information
Application Number:US 14/911,299
Filing Date:2014-07-14
Priority Date:2013-08-14
Art Unit:1765
Classifications
IPC:
C08L23/00C08L23/14C08L23/12
Field of Search:
C08L 23/12C08L 23/14C08L 23/142C08L 2205/025C08L 2308/00
Patent Drawings (1 sheets)
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This patent application is the U.S. national phase of International Application No. PCT/EP2014/065010, filed on Jul. 14, 2014, which claims the benefit of European Patent Application No. 13180389.2, filed Aug. 14, 2013, the disclosures of which are incorporated herein by reference in their entireties for all purposes.
[0002] The present invention is directed to a new polypropylene composition, to its use as a molded article as well as to its manufacture.
[0003] Producing propylene polymer compositions with a proper stiffness-toughness-softness balance is a long-standing problem. There is still a need to design materials with increased softness and toughness, while keeping the melting point high enough so as to ensure thermal stability, e.g. to make materials sterilizable by steam treatment.
[0004] It frequently turns out that improvement of one of these properties is achieved on the expense of the other properties.
[0005] There is still a need to design materials having an improved balance between increased softness and toughness, especially increased toughness at low temperatures, and sufficiently high thermal stability.
[0006] According to a first aspect of the present invention, the object is solved by providing a polypropylene composition comprising comonomer units derived from ethylene in an amount of from 9.0 to 52.0 mol-% and comonomer units derived from at least one C5-12 α-olefin, preferably comonomer units derived from 1-hexene, in an amount of from 0.4 to 3.5 mol-%, wherein said polypropylene composition
- [0007] (a) has an amount of xylene cold solubles (XCS) of at least 30 wt.-%, and
- [0008] (b) fulfills in-equation (I)
IV(XCS)−IV(tot)≦0.30 (I)
[0009] wherein
- [0010] IV(XCS) is the intrinsic viscosity (IV) of the xylene cold soluble (XCS) fraction of the polypropylene composition
- [0011] IV(tot) is the intrinsic viscosity (IV) of the polypropylene composition.
[0012] Preferably, the xylene cold soluble (XCS) fraction of the polypropylene composition according to the first aspect has an amount of
- [0013] (a) ethylene-derived comonomer units of from 20.0 to 80.0 mol-%;
[0014] and/or
- [0015] (b) C5-12 α-olefin-derived comonomer units, preferably 1-hexene derived comonomer units, of from 0.1 to 1.5 mol-%.
[0016] According to a second aspect of the present invention, the object is solved by providing a polypropylene composition comprising comonomer units derived from ethylene in an amount of from 9.0 to 52.0 mol-% and comonomer units derived from at least one C5-12 α-olefin, preferably comonomer units derived from 1-hexene, in an amount of from 0.4 to 3.5 mol-%, wherein said polypropylene composition has an amount of xylene solubles (XS) of at least 30 wt.-%,
[0017] wherein further the xylene solubles (XS) of the polypropylene composition has an amount of
- [0018] (a) ethylene-derived comonomer units of from 20.0 to 80.0 mol-%; and/or
- [0019] (b) C5-12 α-olefin-derived comonomer units, preferably 1-hexene derived comonomer units, of from 0.1 to 1.5 mol-%.
[0020] Preferably, the polypropylene composition according to the second aspect fulfills in-equation (I)
IV(XCS)−IV(tot)≦0.3 (I)
IV(XCS)−IV(tot)≦0.3 (I)
[0021] wherein
- [0022] IV(XCS) is the intrinsic viscosity (IV) of the xylene cold soluble (XCS) fraction of the polypropylene composition;
- [0023] IV(tot) is the intrinsic viscosity (IV) of the polypropylene composition.
[0024] In the following the two aspects of the present invention will be described together in more detail.
[0025] One essential aspect of the present invention is that the polypropylene composition must comprise at least three different monomers, preferably three different monomers, two of which are derived from propylene and ethylene, respectively, whereas the other monomers are derived from at least one C5-12 α-olefin. More preferably the propylene composition consists of monomer units derived from propylene, ethylene and at least one C5-12 α-olefin, still more preferably the propylene composition consists of monomer units derived from propylene, ethylene and 1-hexene and/or 1-octene, yet more preferably the propylene composition consists of monomer units derived from propylene, ethylene and 1-hexene.
[0026] In a preferred embodiment, the polypropylene composition does not contain any butene-derived (such as 1-butene-derived) monomer units.
[0027] In the term “comonomer units” indicates that the units are derived from ethylene and/or C5-12 α-olefin, but not from propylene.
[0028] The polypropylene composition according to this invention comprises comonomer units derived from ethylene in an amount of from 9.0 to 52.0 mol-%, preferably from 10.0 to 50.0 mol-%, more preferably from 11.0 to 45.0 mol-%, still more preferably from 12.0 to 40.0 mol-%, like from 13.0 to 25.0 mol-%.
[0029] As indicated above, the polypropylene composition comprises in addition to propylene and ethylene comonomer units derived from at least one C5-12 α-olefin, preferably derived from 1-hexene and/or 1-octene. The amount of comonomer units derived from at least one C5-12 α-olefin, preferably derived from 1-hexene and/or 1-octene, is from 0.4 to 3.5 mol-%, preferably from 0.4 to 3.0 mol-%, more preferably from 0.4 to 2.0 mol-%, still more preferably from 0.4 to 1.6 mol-%, yet more preferably from 0.4 to 1.3 mol-%.
[0030] The total amount of comonomer units in the polypropylene composition, i.e. units derived from ethylene and at least one C5-12 α-olefin, is preferably from 9.4 to 55.5 mol-%, more preferably from 10.4 to 53.0 mol-%, more preferably from 11.4 to 47.0 mol-%, still more preferably from 12.4 to 41.6 mol-%, like 13.4 to 26.3 mol-%.
[0031] It is further preferred that the polypropylene composition has an intrinsic viscosity (IV) in the range of 1.0 to 3.0 dl/g, like in the range of 1.2 to 3.0 dl/g, more preferably in the range of 1.4 to 2.8 dl/g, like in the range of 1.5 to 2.5 dl/g, still more preferably in the range of 1.5 to 2.2 dl/g.
[0032] Preferably the polypropylene composition has a melt flow rate MFR2 (230° C.) in the range of 0.5 to 100 g/10 min, more preferably in the range of 1.0 to 50 g/10 min, like in the range of 1.0 to 30 g/10 min.
[0033] Preferably the polypropylene composition has a melting temperature of at least 130° C., more preferably in the range of 130 to 155° C., still more preferably in the range of 135 to 150° C., like in the range of 138 to 148° C.
[0034] Further it is preferred that the polypropylene composition has a crystallization temperature of at least 98° C., more preferably in the range of 100 to 118° C., still more preferably in the range of 102 to 115° C. These values are especially applicable in case the polypropylene composition is not nucleated, e.g. not α-nucleated.
[0035] The polypropylene composition according to this invention is preferably heterophasic (see discussion below). Accordingly it is preferred that the polypropylene composition contains elastomeric (co)polymers forming inclusions as a second phase for improving mechanical properties. A polymer containing elastomeric (co)polymers as insertions of a second phase is called heterophasic and is preferably part of the present invention. The presence of second phases or the so called inclusions are for instance visible by high resolution microscopy, like electron microscopy or atomic force microscopy, or by dynamic mechanical thermal analysis (DMTA). Specifically in DMTA the presence of a multiphase structure can be identified by the presence of at least two distinct glass transition temperatures.
[0036] Accordingly it is preferred that the polypropylene composition according to this invention has a glass transition temperature below −25, preferably below −30° C., more preferably in the range of −50 to −25° C., still more preferably in the range of −45 to −30° C.
[0037] The amount of the xylene cold soluble (XCS) fraction of the polypropylene composition is rather high, i.e. at least 30 wt.-%, more preferably is at least 35 wt.-%, still more preferably in the range of 35 to 65 wt.-%, yet more preferably in the range of 35 to 55 wt.-%.
[0038] The polypropylene composition is preferably further featured by the intrinsic viscosity and/or the comonomer content of the xylene cold soluble (XCS) fraction. Accordingly it is preferred that the intrinsic viscosity (IV) of the xylene cold soluble (XCS) fraction is in the range of 1.5 to 4.0 dl/g, more preferably in the range of 1.5 to 3.0 dl/g, still more preferably in the range of 1.5 to 2.5 dl/g, yet more preferably in the range of 1.6 to 2.3 dl/g, like in the range of 1.6 to 2.1 dl/g.
[0039] It is especially preferred that the difference between the intrinsic viscosity (IV) of the xylene cold soluble (XCS) fraction of the polypropylene composition and the intrinsic viscosity (IV) of the total polypropylene composition is rather low. Accordingly it is preferred that the polypropylene composition fulfills in-equation (I), more preferably fulfills in-equation (Ia), yet more preferably fulfills in-equation (Ib),
IV(XCS)−IV(tot)≦0.30 (I);
−2.00≦IV(XCS)−IV(tot)≦0.30 (Ia);
−1.00≦IV(XCS)−IV(tot)≦0.28 (Ib);
IV(XCS)−IV(tot)≦0.30 (I);
−2.00≦IV(XCS)−IV(tot)≦0.30 (Ia);
−1.00≦IV(XCS)−IV(tot)≦0.28 (Ib);
[0040] wherein
- [0041] IV(XCS) is the intrinsic viscosity (IV) of the xylene cold soluble (XCS) fraction of the polypropylene composition
- [0042] IV(tot) is the intrinsic viscosity (IV) of the polypropylene composition.
[0043] Additionally it is preferred that the xylene cold soluble (XCS) fraction comprises, preferably consists of, units derived from propylene, ethylene and at least one C5-12 α-olefin. Still more preferably the xylene cold soluble (XCS) fraction comprises, preferably consists of, units derived from propylene, ethylene and one C5-12 α-olefin. Yet more preferably the xylene cold soluble (XCS) fraction comprises, preferably consists of, units derived from propylene, ethylene and 1-hexene and/or 1-octene. In one especially preferred embodiment the xylene cold soluble (XCS) fraction comprises, preferably consists of, units derived from propylene, ethylene and 1-hexene.
[0044] The xylene cold soluble (XCS) fraction of the polypropylene composition preferably comprises comonomer units derived from ethylene in an amount of from 20.0 to 80.0 mol-%, more preferably from 20.0 to 70.0 mol-%, yet more preferably from 20.0 to 60.0 mol-%, even more preferably from 21.0 to 55.0 mol.-%, like from 22.0 to 40.0 mol.-%.
[0045] In one embodiment the amount of 20 wt-% of ethylene-derived comonomer units in the xylene cold soluble (XCS) fraction of the polypropylene composition is excluded.
[0046] Preferably the amount of comonomer units derived from at least one C5-12 α-olefin, preferably derived from 1-hexene and/or 1-octene, of the xylene cold soluble (XCS) fraction of the polypropylene composition is from 0.1 to 1.5 mol-%, more preferably from 0.1 to 1.4 mol-%, still more preferably from 0.1 to 1.2 mol-%, still more preferably from 0.2 to 1.1 mol-%.
[0047] The total amount of comonomer units in the xylene cold soluble (XCS) fraction of the polypropylene composition, i.e. units derived from ethylene and at least one C5-12 α-olefin, is preferably from 20.1 to 81.5 mol-%, more preferably 20.1 to 71.4 mol-%, yet more preferably from 20.1 to 61.2 mol-%, still more preferably from 21.2 to 56.1 mol-%, like from 22.2 to 41.1 mol.-%.
[0048] In one preferred embodiment the polypropylene composition fulfills in-equation (II), more preferably in-equation (IIa), yet more preferably in-equation (IIb)
[0049]
[0050] wherein
[0051] CX(XCS) is the amount in mol-% of C5-12 α-olefin-derived comonomer units in the xylene cold soluble (XCS) fraction of the polypropylene composition,
[0052] XCS is the amount in wt.-% of xylene cold soluble (XCS) fraction of the polypropylene composition.
[0053] In order to provide sufficient softness, it can be preferred that the polypropylene composition has a tensile modulus of less 500 MPa, more preferably less than 450 MPa, even more preferably in the range of 150 to 450 MPa, like in the range of 200 to 420 MPa.
[0054] In a preferred embodiment the propylene copolymer of the present invention is a blend, preferably a reactor blend, of a propylene copolymer (C) and an elastomeric copolymer (E), e.g. a terpolymer (T). Preferably the propylene copolymer (C) acts as a matrix in which the elastomeric copolymer (E) is dispersed. In other words the propylene copolymer is a heterophasic propylene copolymer (HECO) comprising the propylene copolymer (C) as the matrix (M) in which the elastomeric copolymer (E), e.g. the terpolymer (T), is dispersed.
[0055] The weight ratio between the propylene copolymer (C) and the elastomeric copolymer (E), e.g. the terpolymer (T), [(C)((E)] is 75:25 to 40:60, more preferably 70:30 to 45:55, still more preferably 65:35 to 50:50.
[0056] Preferably the polypropylene composition, e.g. the heterophasic propylene copolymer (HECO), comprises as main components the propylene copolymer (C) and the elastomeric copolymer (E). Other components present in the polypropylene composition, e.g. in the heterophasic propylene copolymer (HECO), can be for instance additives or low amounts of other polymers. “Other polymers” are for example polyethylene (as a side-product of the polymerization process of the polypropylene composition, e.g. of the heterophasic propylene copolymer (HECO), or polymer carrier for the additives. Typically the amount of polymers other than the propylene copolymer (C) and the elastomeric copolymer (E) does not exceed 15 wt.-%, more preferably does not exceed 10 wt.-%, like does not exceed 5 wt.-%, based on the total weight of the polypropylene composition, e.g. of the heterophasic propylene copolymer (HECO). Further the total amount of additives (excluding the so called other polymers), like antioxidants, nucleating agents, slip agents and antistatic agents, are preferably present in an amount of at most 7 wt.-%, more preferably at most 5 wt.-%, like in the range of 0.5 to 5 wt.-%, based on the total weight of the polypropylene composition, e.g. of the heterophasic propylene copolymer (HECO). Accordingly in one embodiment the amount of the propylene copolymer (C) and the elastomeric copolymer (E) together is at least 70 wt.-%, more preferably at least 80 wt.-%, still more preferably at least 85 wt.-%, yet more preferably at least 90 wt.-%, like at least 95 wt.-%.
[0057] The elastomeric copolymer (E) preferably is a terpolymer (T) or higher copolymer of units derived from propylene, ethylene and at least one C5-12 α-olefin. In one preferred embodiment the elastomeric copolymer (E) is a terpolymer (T) of units derived from propylene, ethylene and one C5-12 α-olefin. Yet more preferably elastomeric copolymer (E) is a terpolymer (T) of units derived from propylene, ethylene and 1-hexene and/or 1-octene. In one especially preferred embodiment the elastomeric copolymer (E) is a terpolymer (T) of units derived from propylene, ethylene and 1-hexene.
[0058] Preferably the elastomeric copolymer (E), e.g. the terpolymer (T), comprises comonomer units derived from ethylene in an amount of from 20.0 to 80.0 mol-%, more preferably from 22.0 to 70.0 mol-%, yet more preferably from 22.0 to 60.0 mol-%, still more preferably from 24.0 to 55.0 mol-%, like from 25.0 to 52.0 mol.-%.
[0059] Preferably the amount of comonomer units derived from at least one C5-12 α-olefin, preferably derived from 1-hexene and/or 1-octene, of the elastomeric copolymer (E), e.g. of the terpolymer (T), is from 0.05 to 2.0 mol-%, more preferably from 0.1 to 2.0 mol-%, still more preferably from 0.1 to 1.5 mol-%, still more preferably from 0.1 to 1.0 mol-%.
[0060] The total amount of comonomer units, i.e. units derived from ethylene and at least one C5-12 α-olefin, of the elastomeric copolymer (E), e.g. of the terpolymer (T), is preferably from 20.05 to 82.0 mol-%, more preferably 20.1 to 72.0 mol-%, yet more preferably from 22.1 to 61.5 mol-%, still more preferably from 24.1 to 56.0 mol-%, like from 25.1 to 53.0 mol.-%.
[0061] As mentioned above the matrix (M) of the polypropylene composition in which the elastomeric copolymer (E), e.g. the terpolymer (T), is dispersed is a propylene copolymer (C) of units derived from propylene and at least one C5-12 α-olefin. In other words the matrix (M) does not encompass units derived from ethylene. In one preferred embodiment the propylene copolymer (C) acting as the matrix (M) is a propylene copolymer of units derived from propylene and one C5-12 α-olefin. Yet more preferably the propylene copolymer (C) consists of units derived from propylene, 1-hexene and/or 1-octene. In one especially preferred embodiment the propylene copolymer (C) consists of units derived from propylene and 1-hexene.
[0062] Preferably the amount of comonomer units derived from at least one C5-12 α-olefin, preferably derived from 1-hexene and/or 1-octene, of the propylene copolymer (C) is from 0.8 to 8.0 mol-%, more preferably from 0.9 to 7.0 mol-%, still more preferably from 0.9 to 5.0 mol-%, like from 0.9 to 3.0 mol-%.
[0063] The amount of the xylene cold soluble (XCS) fraction of the propylene copolymer (C) depends to great extent on the amount of comonomer units derived from at least one C5-12 α-olefin. Accordingly it is preferred that the propylene copolymer (C) has a xylene cold soluble (XCS) content of not more than 38 wt.-%, more preferably of not more than 30 wt.-%, even more preferably in the range of 1 to 38 wt.-%, still more preferably in the range of 2 to 33 wt.-%, yet more preferably in the range of 3 to 25 wt.-%.
[0064] Preferably the propylene copolymer (C) has an intrinsic viscosity (IV) is in the range of 0.8 to 3.0 dl/g, more preferably in the range of 1.0 to 2.5 dl/g, still more preferably in the range of 1.2 to 2.0 dl/g.
[0065] In a preferred embodiment the propylene copolymer (C) has a melt flow rate MFR2 (230° C.) in the range of 1 to 200 g/10 min, more preferably in the range of 5 to 100 g/10 min, still more preferably in the range of 10 to 60 g/10 min.
[0066] In one preferred embodiment the propylene copolymer (C) comprises at least two polypropylene fractions, at least one of said polypropylene fractions is a propylene copolymer fraction (CF) of units derived from propylene and at least one C5-12 α-olefin. Still more preferably the propylene copolymer (C) consists of two polypropylene fractions, at least one of said two polypropylene fractions is a propylene copolymer fraction (CF) of units derived from propylene and at least one C5-12 α-olefin.
[0067] Accordingly in one embodiment the propylene copolymer (C) comprises at least two propylene copolymer fractions (CF1) and (CF2), more preferably consists of two propylene copolymer fractions (CF1) and (CF2), both of said propylene copolymer fractions are propylene copolymer fractions of units derived from propylene and at least one C5-12 α-olefin. In one preferred embodiment the propylene copolymer (C) comprises at least two propylene copolymer fractions (CF1) and (CF2), more preferably consists of two propylene copolymer fractions (CF1) and (CF2), both of said propylene copolymer fractions are propylene copolymer fractions of units derived from propylene and one C5-12 α-olefin, i.e. 1-hexene or 1-octene.
[0068] In case the propylene copolymer (C) comprises two, preferably consists of two, propylene copolymer fractions (CF1) and (CF2) both fractions differ in the amount of comonomer units derived from at least one C5-12 α-olefin, e.g. the propylene copolymer fraction (CF1) is the comonomer lean fraction and the propylene copolymer fraction (CF2) is the comonomer rich fraction. Preferably the amount of comonomer units derived from at least one C5-12 α-olefin, preferably derived from 1-hexene and/or 1-octene, of the propylene copolymer fraction (CF1) is from 0.05 to 2.0 mol-%, more preferably from 0.1 to 1.5 mol-%, still more preferably from 0.2 to 1.0 mol-%. On the other hand the amount of comonomer units derived from at least one C5-12 α-olefin, preferably derived from 1-hexene and/or 1-octene, of the propylene copolymer fraction (CF2) is from 1.0 to 12.0 mol-%, more preferably from 2.0 to 10.0 mol-%, still more preferably from 3.0 to 8.0 mol-%, like 3.0 to 6.0 mol-%, preferably with the proviso that the amount of comonomers in the propylene copolymer fraction (CF2) is higher than in the propylene copolymer fraction (CF1). Preferably in both propylene copolymer fractions (CF1) and (CF2) the same comonomers derived from C5-12 α-olefin are present, e.g. 1-hexene or 1-octene.
[0069] The weight fraction between the propylene copolymer fractions (CF1) and (CF2) [(CF1)/(CF2)] is preferably between 75/25 to 30/70, more preferably between 70/30 to 40/60, like 70/30 to 45/55.
[0070] Accordingly in one embodiment the polypropylene composition, e.g. the heterophasic propylene copolymer (HECO), comprises
- [0071] (a) 20 to 50 wt.-%, more preferably 23 to 45 wt.-%, still more preferably 25 to 40 wt.-%, of the propylene copolymer fraction (CF1)
- [0072] (b) 15 to 40 wt.-%, more preferably 16 to 35 wt.-%, still more preferably 16 to 32 wt.-%, of the propylene copolymer fraction (CF2)
- [0073] (c) 25 to 60 wt.-%, more preferably 30 to 55 wt.-%, still more preferably 35 to 50 wt.-%, of the elastomeric copolymer (E), e.g. of the terpolymer (T),
[0074] based on the total weight of the propylene copolymer fraction (CF1), the propylene copolymer fraction (CF2) and the elastomeric copolymer (E), e.g. the terpolymer (T), together.
[0075] In another preferred embodiment the propylene copolymer (C) comprises at least two polypropylene fractions, more preferably consists of two polypropylene fractions, one of said polypropylene fractions is a propylene homopolymer fraction (HF1) and the other is a propylene copolymer fraction (CF1′) of units derived from propylene and at least one C5-12 α-olefin. In a still more preferred embodiment the propylene copolymer (C) comprises at least two polypropylene fractions, more preferably consists of two polypropylene fractions, one of said two polypropylene fractions is a propylene homopolymer fraction (HF1) and the other is a propylene copolymer fraction (CF1′) of units derived from propylene and one C5-12 α-olefin, i.e. 1-hexene or 1-octene.
[0076] The expression homopolymer used in the instant invention relates to a polypropylene that consists of more than 99.90 mol-%, more preferably of more than 99.95 mol-%, of propylene units. In a preferred embodiment only propylene units in the propylene homopolymer are detectable. Accordingly the propylene homopolymer fraction (HF1) complies with the definition in this paragraph.
[0077] On the other hand the amount of comonomer units derived from at least one C5-12 α-olefin, preferably derived from 1-hexene and/or 1-octene, of the propylene copolymer fraction (CF1′) is from 1.0 to 15.0 mol-%, more preferably from 2.0 to 12.0 mol-%, still more preferably from 2.5 to 10.0 mol-%, like 2.8 to 8.0 mol-%.
[0078] The weight fraction between the polypropylene fractions (HF1) and (CF1′) [(HF1)/(CF1′)] is preferably between 75/25 to 30/70, more preferably between 70/30 to 40/60, like 70/30 to 45/55.
[0079] Accordingly in one embodiment the polypropylene composition, e.g. the heterophasic propylene copolymer (HECO), comprises
- [0080] (a) 20 to 50 wt.-%, more preferably 23 to 45 wt.-%, still more preferably 25 to 40 wt.-%, of the propylene homopolymer fraction (HF1)
- [0081] (b) 15 to 40 wt.-%, more preferably 16 to 35 wt.-%, still more preferably 16 to 32 wt.-%, of the propylene copolymer fraction (CF1′)
- [0082] (c) 25 to 60 wt.-%, more preferably 30 to 55 wt.-%, still more preferably 35 to 50 wt.-%, of the elastomeric copolymer (E), e.g. of the terpolymer (T),
[0083] based on the total weight of the propylene homopolymer fraction (HF1), the propylene copolymer fraction (CF1′) and the elastomeric copolymer (E), e.g. the terpolymer (T), together.
[0084] According to a further aspect, the present invention provides a molded article comprising the polypropylene composition as defined above.
[0085] The molded article can be prepared by any known molding process, such as injection molding (i.e. injection-molded article) or extrusion molding (i.e. extrusion-molded article).
[0086] Preferably the polypropylene composition is preferably obtained by a process as defined in more detail below.
[0087] The polypropylene composition, e.g. the heterophasic propylene copolymer (HECO), according to this invention is preferably produced in the presence of the catalyst or catalyst composition as defined in detail below. Preferably the polymerization takes place in a sequential polymerization system comprising at least two polymerization reactors (R1) and (R2). However it is especially preferred that the polypropylene composition, e.g. the heterophasic propylene copolymer (HECO), is produced in a sequential polymerization process comprising at least three one polymerization reactors (R1), (R2) and (R3). Further the process may also comprise a pre-polymerization reactor (PR). The term “pre-polymerization” as well as the term “pre-polymerization reactor (PR)” indicates that this is not the main polymerization in which the polypropylene composition, e.g. the heterophasic propylene copolymer (HECO), is produced. In turn in the “at least two polymerization reactors (R1) and (R2)” takes the main polymerization place, i.e. where polypropylene composition, e.g. the heterophasic propylene copolymer (HECO), is produced. That means the expression “polymerization reactor” does not include the pre-polymerization reactor (PR). Thus, in case the process “consists of” two polymerization reactors (R1) and (R2) or three polymerization reactors (R1); (R2) and (R3), this definition does by no means exclude that the overall process comprises the pre-polymerization step in a pre-polymerization reactor. The term “consist of” is only a closing formulation in view of the main polymerization reactors.
[0088] Typically the weight ratio of the polypropylene (Pre-PP), e.g. of the propylene copolymer (Pre-PPC), produced in pre-polymerization reactor (PR) and the catalyst is below 500 g Pre-PP/g cat, more preferably in the range of 1 to 300 g pre-PP/g cat, still more preferably in the range of 5 to 200 g Pre-PP/g cat, yet more preferably in the range of 10 to 100 g Pre-PP/g cat.
[0089] In the pre-polymerization step the same monomers can be polymerized like in the main polymerization, or just propylene. In one embodiment, just propylene is polymerized in the pre-polymerization reactor.
[0090] The pre-polymerization reaction is preferably conducted at an operating temperature of more than 0 to 60° C., preferably from 5 to 50° C., and more preferably from 15 to 40° C., like from 20 to 30° C.
[0091] The pressure in the pre-polymerization reactor is not critical but must be sufficiently high to maintain the reaction mixture in liquid phase. Thus, the pressure may be from 5 to 100 bar, for example 10 to 70 bar.
[0092] The average residence time (τ) is defined as the ratio of the reaction volume (VR) to the volumetric outflow rate from the reactor (Qo) (i.e. VR/Qo), i.e. i=VR/Qo [tau=VR/Qo]. In case of a loop reactor the reaction volume (VR) equals to the reactor volume.
[0093] The average residence time (τ) in the pre-polymerization reactor (PR) is preferably in the range of 3 to 50 min, still more preferably in the range of more than 8 to 45 min, like in the range of 10 to 30 min.
[0094] In a preferred embodiment, the pre-polymerization is conducted as bulk slurry polymerization in liquid propylene and optional comonomer, i.e. the liquid phase mainly comprises propylene and optional comonomer, with optionally inert components dissolved therein. Furthermore, according to the present invention, a hydrogen (H2) feed can be employed during pre-polymerization as mentioned above.
[0095] The pre-polymerization is conducted in the presence of the catalyst or catalyst composition as defined below. Accordingly the complex and the optional cocatalyst (Co) are introduced to the pre-polymerization step. However, this shall not exclude the option that at a later stage for instance further cocatalyst is added in the polymerization process, for instance in the first reactor (R1). In a preferred embodiment the complex and the cocatalyst are only added in the pre-polymerization reactor (PR).
[0096] It is possible to add other components also to the pre-polymerization stage. Thus, antistatic additive may be used to prevent the particles from adhering to each other or to the walls of the reactor.
[0097] The precise control of the pre-polymerization conditions and reaction parameters is within the skill of the art.
[0098] Subsequent to the pre-polymerization—if used—the mixture of the complex or complex composition and the polypropylene (Pre-PP), like the propylene copolymer (Pre-PPC), produced in the pre-polymerization reactor (PR) is transferred to the first reactor (R1). Typically the total amount of the polypropylene (Pre-PP), like the propylene copolymer (Pre-PPC), in the final copolymer (PPC) is rather low and typically not more than 5.0 wt.-%, more preferably not more than 4.0 wt.-%, still more preferably in the range of 0.1 to 4.0 wt.-%, like in the range 0.2 of to 3.0 wt.-%.
[0099] The polymerization reactor (R1) can be a gas phase reactor (GPR) or slurry reactor (SR). Preferably the polymerization reactor (R1) is a slurry reactor (SR) and can be any continuous or simple stirred batch tank reactor or loop reactor operating in bulk or slurry. Bulk means a polymerization in a reaction medium that comprises of at least 60% (w/w) monomer. According to the present invention the slurry reactor (SR) is preferably a (bulk) loop reactor (LR).
[0100] The polymer produced in the polymerization reactor (R1), like in the loop reactor (LR1), is directly fed into the polymerization reactor (R2), e.g. into a loop reactor (LR2) or gas phase reactor (GPR-1), without a flash step between the stages. This kind of direct feed is described in EP 887379 A, EP 887380 A, EP 887381 A and EP 991684 A. By “direct feed” is meant a process wherein the content of the first polymerization reactor (R1), i.e. of the loop reactor (LR), the polymer slurry comprising the first fraction of the polypropylene composition, e.g. of the heterophasic propylene copolymer (HECO), is led directly to the next stage gas phase reactor.
[0101] Alternatively, the first fraction of polypropylene composition, e.g. of the heterophasic propylene copolymer (HECO), i.e. the polymer of the polymerization reactor (R1), may be also directed into a flash step or through a further concentration step before fed into the polymerization reactor (R2), e.g. into the loop reactor (LR2) or the gas phase reactor (GPR-1). Accordingly, this “indirect feed” refers to a process wherein the content of the first polymerization reactor (R1), of the loop reactor (LR), i.e. the polymer slurry, is fed into the second polymerization reactor (R2), e.g. into the loop reactor (LR2) or the first gas phase reactor (GPR-1), via a reaction medium separation unit and the reaction medium as a gas from the separation unit.
[0102] A gas phase reactor (GPR) according to this invention is preferably a fluidized bed reactor, a fast fluidized bed reactor or a settled bed reactor or any combination thereof.
[0103] More specifically, the polymerization reactor (R2), the polymerization reactor (R3) and any subsequent polymerization reactor, if present, are preferably gas phase reactors (GPRs). Such gas phase reactors (GPR) can be any mechanically mixed or fluid bed reactors. Preferably the gas phase reactors (GPRs) comprise a mechanically agitated fluid bed reactor with gas velocities of at least 0.2 m/sec. Thus it is appreciated that the gas phase reactor is a fluidized bed type reactor preferably with a mechanical stirrer.
[0104] Thus in a preferred embodiment the first polymerization reactor (R1) is a slurry reactor (SR), like loop reactor (LR), whereas the second polymerization reactor (R2), the third polymerization reactor (R3) and any optional subsequent polymerization reactor are gas phase reactors (GPR). Prior to the slurry reactor (SR) a pre-polymerization reactor can placed according to the present invention.
[0105] A preferred multistage process is a “loop-gas phase”-process, such as developed by Borealis A/S, Denmark (known as BORSTAR® technology) described e.g. in patent literature, such as in EP 0 887 379, WO 92/12182 WO 2004/000899, WO 2004/111095, WO 99/24478, WO 99/24479 or in WO 00/68315.
[0106] A further suitable slurry-gas phase process is the Spheripol® process of Basell.
[0107] The operating temperature in the polymerization reactor (R1), i.e. in the loop reactor (LR), is in the range of 50 to 130° C., more preferably in the range of 60 to 100° C., still more preferably in the range of 65 to 90° C., yet more preferably in the range of 70 to 90° C., like in the range of 70 to 80° C.
[0108] On the other hand the operating temperature of the polymerization reactors (R2 and R3), i.e. of the first and second gas phase reactors (GPR1 and GPR2), is in the range of 60 to 100° C., more preferably in the range of 70 to 95° C., still more preferably in the range of 75 to 90° C., yet more preferably in the range of 78 to 85° C. In one embodiment the operating temperature of the polymerization reactor (R3), i.e. of the second gas phase reactor (GPR2), and any optional subsequent gas phase reactors (GPR) is in the range of 60 to 85° C., more preferably in the range of 65 to 80° C.
[0109] Typically the pressure in the polymerization reactor (R1), preferably in the loop reactor (LR), is in the range of from 28 to 80 bar, preferably 32 to 60 bar, whereas the pressure in the second polymerization reactor (R2), i.e. in the first gas phase reactor (GPR-1), and in the third polymerization reactor (R3), i.e. in the second gas phase reactor (GPR-2), and in any subsequent polymerization reactor, if present, is in the range of from 5 to 50 bar, preferably 15 to 35 bar.
[0110] Preferably hydrogen is added in each polymerization reactor in order to control the molecular weight, i.e. the melt flow rate MFR2.
[0111] The residence time can vary in the reactor zones.
[0112] For instance the average residence time (τ) in the bulk reactor, e.g. in the loop reactor (LR), is in the range 0.2 to 4 hours, e.g. 0.3 to 1.5 hours and the average residence time (τ) in gas phase reactor(s) will generally be 0.2 to 6.0 hours, like 0.5 to 4.0 hours.
[0113] Accordingly the polymerization of the polypropylene composition, e.g. of the heterophasic propylene copolymer (HECO), takes place in a sequential polymerization process comprising, preferably consisting of, the polymerization reactors (R1) and (R2) and optional (R3), in which the polymerization reactor (R1) is preferably a slurry reactor (SR1), e.g. a loop reactor (LR1), whereas the polymerization reactors (R2) and (R3) are gas phase reactors (GPR1) and (GPR2). Preferably upstream to the polymerization reactor (R1) a pre-polymerization reactor (PR) is arranged in which the pre-polymerization takes place.
[0114] In case the polypropylene composition, e.g. the heterophasic propylene copolymer (HECO), is produced in two polymerization reactors (R1) and (R2), the matrix (M) of the polypropylene composition, i.e. the propylene copolymer (C), is produced in the polymerization reactor (R1), like the slurry reactor (SR), e.g. the loop reactor (LR), whereas the elastomeric copolymer (E), e.g. the terpolymer (T), is produced in the polymerization reactor (R2), e.g. in the gas phase reactor (GPR-1). In such a case in the polymerization reactor (R1), like in the slurry reactor (SR), e.g. in the loop reactor (LR), propylene and at least one C5-12 α-olefin, like 1-hexene or 1-octene, are polymerized in the presence of a catalyst or a catalyst composition as defined in detail below obtaining thereby the propylene copolymer (C). The obtained propylene copolymer (C) is subsequently transferred in the polymerization reactor (R2) in which in the presence of the propylene copolymer (C) the elastomeric copolymer (E), e.g. the terpolymer (T), is produced. In the polymerization reactor (R2) propylene, ethylene and optionally at least one C5-12 α-olefin, like 1-hexene or 1-octene, is fed. However in a preferred embodiment only propylene and ethylene is fed, whereas the excess of the at least one C5-12 α-olefin, like the excess of the 1-hexene or of the 1-octene, from the polymerization reactor (R1) is consumed. Preferably in both polymerization reactors (R1) and (R2) the same catalyst or catalyst composition is used, even more preferred the catalyst or catalyst composition of the polymerization reactor (R1) is transferred to the polymerization reactor (R2).
[0115] In case the polypropylene composition, e.g. the heterophasic propylene copolymer (HECO), is produced in three or four polymerization reactors (R1), (R2), (R3) and optional (R4), the matrix (M) of the polypropylene composition, i.e. the propylene copolymer (C), is produced in the polymerization reactor (R1), like in the slurry reactor (SR1), e.g. in the loop reactor (LR1), and the polymerization reactor (R2), like in the slurry reactor (SR2), e.g. the loop reactor in (LR2), or in the gas phase reactor (GPR-1), whereas the elastomeric copolymer (E), e.g. the terpolymer (T), is produced in the polymerization reactor (R3), e.g. in the gas phase reactor (GPR-2) and in the optional polymerization reactor (R4), e.g. in the optional gas phase reactor (GPR-3). In such a case in the polymerization reactor (R1), like in the slurry reactor (SR1), e.g. in the loop reactor (LR1), propylene and optionally at least one C5-12 α-olefin, like 1-hexene or 1-octene, is/are polymerized in the presence of a catalyst or catalyst composition as defined in detail below obtaining thereby the propylene copolymer fraction (CF1) or the propylene homopolymer fraction (HF1), the latter preferred. In case of the production of the propylene homopolymer fraction (HF1) only propylene as monomer is fed into the polymerization reactor (R1). The thus obtained propylene copolymer fraction (CF1) or propylene homopolymer fraction (HF1) is subsequently transferred in the second polymerization reactor (R2) in which in the presence of the propylene copolymer fraction (CF1) or the propylene homopolymer fraction (HF1) a propylene copolymer fraction is produced. Accordingly in the second polymerization reactor (R2) propylene and at least one C5-12 α-olefin, like 1-hexene or 1-octene, is fed obtaining either the propylene copolymer fraction (CF1′) (in case in the polymerization reactor (R1) the propylene homopolymer fraction (HF1) was produced) or the propylene copolymer fraction (CF2) (in case in the polymerization reactor (R1) the propylene copolymer fraction (CF1) was produced). Concerning the definition of (HF1), (CF1), (CF1′) and (CF2) reference is made to the information provided above. The mixture of the propylene homopolymer fraction (HF1) and the propylene copolymer fraction (CF1′) or the mixture of the propylene copolymer fraction (CF1) and the propylene copolymer fraction (CF2) is the matrix (M), i.e. the propylene copolymer (C). Subsequently the elastomeric copolymer (E), e.g. the terpolymer (T), is produced in the polymerization reactor (R3). In the polymerization reactor (R3) propylene, ethylene and optionally at least one C5-12 α-olefin, like 1-hexene or 1-octene, is fed. However in a preferred embodiment only propylene and ethylene is fed, whereas the excess of the at least one C5-12 α-olefin, like the excess of the 1-hexene or of the 1-octene, from the polymerization reactor (R2) is consumed. Preferably in all reactors (R1), (R2) and (R3) the same catalyst or catalyst composition is used, even more preferred the catalyst or catalyst composition of the polymerization reactor (R1) is transferred to the polymerization reactor (R2) and from the polymerization reactor (R2) to the polymerization reactor (R3).
[0116] Accordingly in all polymerization reactors the same catalyst or catalyst composition as defined below is preferably present.
[0117] The catalyst used in the process must contain a substituted bisindenyl metallocene complex, in which the two indenyl ligands are connected by a chemical link (the “bridge”)
[0118] Additionally the catalyst must comprise a cocatalyst.
[0119] Preferably the molar-ratio of cocatalyst (Co) to the metal (M) of the complex, like Zr, [Co/M] is below 500, more preferably in the range of more than 100 to below 500, still more preferably in the range of 150 to 450, yet more preferably in the range of 200 to 450.
[0120] In one embodiment the catalyst is used in the form of a catalyst composition, said composition comprises a polymer in which the catalyst is distributed. The term “distributed” in this regard shall preferably indicate that the catalyst system is not concentrated at one place within the polymer but (evenly) dispersed within the polymer. This has the advantage that—contrary to commercially available supported catalyst systems—an overheating at the beginning of the polymerization process due to “hot spots” areas caused by concentration of catalytic species at one place is diminished which in turn supports a start of the polymerization in a controlled way under mild conditions. The even distribution of catalyst in polymer is mainly achieved due to the manufacture of the catalyst composition as described in WO 2010/052260. One remarkable feature of the process is that the catalyst composition is obtained by heterogeneous catalysis, i.e. the catalyst used in the preparation of the catalyst composition is in solid form when polymerizing at least one olefin monomer, preferably at least one α-olefin monomer, like propylene, to the in which then the catalyst is dispersed. Thus the catalyst if dispersed in a polymer is obtainable, preferably obtained, by heterogeneous catalysis using the solid catalyst as defined in the instant invention.
[0121] A further characteristic of the catalyst composition according to the present invention is that the catalyst within the catalyst composition is protected against dissolution phenomena in a slurry reactor, i.e. in low molar mass hydrocarbons, like propane, iso-butane, pentane, hexane or propylene. On the other hand the protection of the catalyst should be not too massive otherwise the catalytic activity of the active species might be deteriorated. In the present invention the conflicting interests one the one hand of high catalytic activity of the catalyst and on the other hand of the solid stability of the catalyst in the polymerization medium of the slurry reactor is achieved by protecting the catalyst by a polymer wherein the polymer is present in rather low amounts within the catalyst composition. Rather low weight ratio of polymer to catalyst [weight polymer/weight catalyst], also named polymerization degree, leads to a satisfactory protection against dissolution by keeping the catalyst on high levels. Accordingly it is appreciated that the polymerization degree [weight polymer/weight catalyst] is below 25.0, more preferably below 15.0, yet more preferably below 10.0, still yet more preferably below 5.0. On the other hand to achieve a reasonable protection against dissolution the polymerization degree [weight polymer/weight catalyst] shall preferably exceed a value of 0.5, more preferably of 0.7, yet more preferably of 1.0. Preferred ranges of the polymerization degree [weight polymer/weight catalyst] shall be 0.7 to 10.0, more preferably 1.0 to 8.0, yet more preferably 1.0 to 6.0, still more preferably 1.0 to 5.0, still yet more preferably of 2.0 to 5.0.
[0122] The polymer can be any type of polymer as long as it prevents the dissolution of the catalyst in the polymerization medium of a slurry reactor, i.e. low molar mass hydrocarbons, like propane, iso-butane, pentane, hexane or propylene, and is catalytically inert. Accordingly the polymer is preferably based on olefin monomers, like α-olefin monomers, each having 2 to 20 carbon atoms. The olefin, like α-olefin, can be linear or branched, cyclic or acyclic, aromatic or aliphatic. Preferred examples are ethylene, propylene, 1-butene, 3-methyl-1-butene, 3-methyl-1-pentene, 4-methyl-1-pentene and vinylcyclohexane.
[0123] It is in particular preferred that the polymer corresponds to the polymer which shall be produced with the inventive solid catalyst composition. Accordingly it is preferred that the polymer is preferably a polymer selected from the group consisting of ethylene homopolymer, ethylene copolymer, propylene homopolymer and propylene copolymer. In one embodiment the polymer is a propylene homopolymer.
[0124] Concerning the preparation of the catalyst composition as defined above reference is made to WO 2010/052260.
[0125] The single site metallocene complex, especially the complexes defined by the formulas specified in the present invention, used for manufacture of the propylene copolymer are those described by formula (I)
[0126]
[0127] wherein
- [0128] M is zirconium (Zr) or hafnium (Hf), preferably zirconium (Zr);
- [0129] X are ligands with a σ-bond to the metal “M”, preferably those as defined above for formula (I), preferably chlorine (Cl) or methyl (CH3), the former especially preferred, The term “σ-ligand” is understood in the whole description in a known manner, i.e. a group bound to the metal via a sigma bond. Thus the anionic ligands “X” can independently be halogen or be selected from the group consisting of R′, OR′, SiR′3, OSiR′3, OSO2CF3, OCOR′, SR′, NR′2 or PR′2 group wherein R′ is independently hydrogen, a linear or branched, cyclic or acyclic, C1 to C20 alkyl, C2 to C20 alkenyl, C2 to C20 alkynyl, C3 to C12 cycloalkyl, C6 to C20 aryl, C7 to C20 arylalkyl, C7 to C20 alkylaryl, C8 to C20 arylalkenyl, in which the R′ group can optionally contain one or more heteroatoms belonging to groups 14 to 16, in preferred embodiments the anionic ligands “X” are identical and either halogen, like Cl, or methyl or benzyl, the most preferred monovalent anionic ligand is halogen, in particular chlorine (Cl);
- [0130] R1 are equal to or different from each other, preferably equal to, and are selected from the group consisting of linear saturated C1 to C20 alkyl, linear unsaturated C1 to C20 alkyl, branched saturated C1-C20 alkyl, branched unsaturated C1 to C20 alkyl, C3 to C20 cycloalkyl, C6 to C20 aryl, C7 to C20 alkylaryl, and C7 to C20 arylalkyl, optionally containing one or more heteroatoms of groups 14 to 16 of the Periodic Table (IUPAC), preferably are equal to or different from each other, preferably equal to, and are C1 to C10 linear or branched hydrocarbyl, more preferably are equal to or different from each other, preferably equal to, and are C1 to C6 linear or branched alkyl;
- [0131] R2 to R6 are equal to or different from each other and are selected from the group consisting of hydrogen, linear saturated C1-C20 alkyl, linear unsaturated C1-C20 alkyl, branched saturated C1-C20 alkyl, branched unsaturated C1-C20 alkyl, C3-C20 cycloalkyl, C6-C20 aryl, C7-C20 alkylaryl, and C7-C20 arylalkyl, optionally containing one or more heteroatoms of groups 14 to 16 of the Periodic Table (IUPAC), preferably are equal to or different from each other and are C1 to C10 linear or branched hydrocarbyl, more preferably are equal to or different from each other and are C1 to C6 linear or branched alkyl,
- [0132] R7 and R8 are equal to or different from each other and are selected from the group consisting of hydrogen, linear saturated C1 to C20 alkyl, linear unsaturated C1 to C20 alkyl, branched saturated C1 to C20 alkyl, branched unsaturated C1 to C20 alkyl, C3 to C20 cycloalkyl, C6 to C20 aryl, C7 to C20 alkylaryl, C7 to C20 arylalkyl, optionally containing one or more heteroatoms of groups 14 to 16 of the Periodic Table (IUPAC), SiR103, GeR103, OR10, SR10 and NR102,
- [0133] wherein
- [0134] R10 is selected from the group consisting of linear saturated C1-C20 alkyl, linear unsaturated C1 to C20 alkyl, branched saturated C1 to C20 alkyl, branched unsaturated C1 to C20 alkyl, C3 to C20 cycloalkyl, C6 to C20 aryl, C7 to C20 alkylaryl, and C7 to C20 arylalkyl, optionally containing one or more heteroatoms of groups 14 to 16 of the Periodic Table (IUPAC),
- [0135] and/or
- [0136] R7 and R8 are optionally part of a C4 to C20 carbon ring system together with the indenyl carbons to which they are attached, preferably a C5 or C6 ring, optionally one carbon atom of such ring can be replaced by a silicon, sulfur or oxygen atom, where each carbon or silicon atom of such ring has its valence saturated by H or R10 groups, and N, when present, is either part of an aromatic cycle or carries an R10 group, where R10 is as described above,
- [0137] with the proviso that at least two of R7 and R8 are different from H;
- [0138] R9 are equal to or different from each other and are selected from the group consisting of hydrogen, linear saturated C1 to C20 alkyl, linear unsaturated C1 to C20 alkyl, branched saturated C1 to C20 alkyl, branched unsaturated C1 to C20 alkyl, C3 to C20 cycloalkyl, C6 to C20 aryl, C7 to C20 alkylaryl, C7 to C20 arylalkyl, OR10, and SR10, preferably R9 are equal to or different from each other and are H or CH3,
- [0139] wherein R10 is defined as before,
- [0140] L is a bivalent group bridging the two indenyl ligands, preferably being a C2R114 unit or a SiR112 or GeR112, wherein,
- [0141] R11 is selected from the group consisting of H, linear saturated C1 to C20 alkyl, linear unsaturated C1 to C20 alkyl, branched saturated C1 to C20 alkyl, branched unsaturated C1 to C20 alkyl, C3 to C20 cycloalkyl, C6 to C20 aryl, C7 to C20 alkylaryl or C7 to C20 arylalkyl, optionally containing one or more heteroatoms of groups 14 to 16 of the Periodic Table (IUPAC),
- [0142] preferably Si(CH3)2, SiCH3C6H11, or SiPh2,
- [0143] wherein C6H11 is cyclohexyl.
[0144] Preferably the residues R1 are equal to or different from each other, more preferably equal, and are selected from the group consisting of linear saturated C1 to C10 alkyl, linear unsaturated C1 to C10 alkyl, branched saturated C1 to C10 alkyl, branched unsaturated C1 to C10 alkyl and C7 to C12 arylalkyl. Even more preferably the residues R1 are equal to or different from each other, more preferably equal, and are selected from the group consisting of linear saturated C1 to C6 alkyl, linear unsaturated C1 to C6 alkyl, branched saturated C1 to C6 alkyl, branched unsaturated C1 to C6 alkyl and C7 to C10 arylalkyl. Yet more preferably the residues R1 are equal to or different from each other, more preferably equal, and are selected from the group consisting of linear or branched C1 to C4 hydrocarbyl, such as for example methyl or ethyl.
[0145] Preferably the residues R2 to R6 are equal to or different from each other and linear saturated C1 to C4 alkyl or branched saturated C1 to C4 alkyl. Even more preferably the residues R2 to R6 are equal to or different from each other, more preferably equal, and are selected from the group consisting of methyl, ethyl, iso-propyl and tert-butyl.
[0146] In one preferred embodiment, the transition metal compound is rac-dimethylsilanediyl bis(2-methyl-4-phenyl-1,5,6,7-tetrahydro-s-indacen-1-yl)zirconium dichloride.
[0147] In another preferred embodiment, the transition metal compound is rac-dimethylsilanediyl bis(2-methyl-4-phenyl-5-methoxy-6-tert-butylindenyl)zirconium dichloride.
[0148] In a preferred embodiment, the metallocene complexes are asymmetrical. That means that the two indenyl ligands forming the metallocene complex are different, that is, each indenyl ligand bears a set of substituents that are either chemically different, or located in different positions with respect to the other indenyl ligand. More precisely, they are chiral, racemic bridged bisindenyl metallocene complexes. Whilst the complexes of the invention may be in their syn configuration ideally, they are in their anti configuration. For the purpose of this invention, racemic-anti means that the two indenyl ligands are oriented in opposite directions with respect to the cyclopentadienyl-metal-cyclopentadienyl plane, while racemic-syn means that the two indenyl ligands are oriented in the same direction with respect to the cyclopentadienyl-metal-cyclopentadienyl plane, as shown in the Figure below.
[0149]
[0150] Formula (I) is intended to include and the anti configuration. It is required in addition, that the group R5 is not hydrogen where the 5-position in the other ligand carries a hydrogen.
[0151] In fact, the metallocene complexes of use in the invention are C1-symmetric but they maintain a pseudo-C2-symmetry since they maintain C2-symmetry in close proximity of the metal center, although not at the ligand periphery. As will be seen, the use of two different indenyl ligands as described in this invention allows for a much finer structural variation, hence a more precise tuning of the catalyst performance, compared to the typical C2-symmetric catalysts. By nature of their chemistry, both anti and syn enantiomer pairs are formed during the synthesis of the complexes. However, by using the ligands of this invention, separation of the preferred anti isomers from the syn isomers is straightforward.
[0152] It is preferred if the metallocene complexes of the invention are employed as the rac anti isomer. Ideally therefore at least 95% mol, such as at least 98% mol, especially at least 99% mol of the metallocene catalyst is in the racemic anti isomeric form.
[0153] In the complex of use in the invention:
[0154] M is preferably Zr.
[0155] Each X, which may be the same or different, is preferably a hydrogen atom, a halogen atom, a R, OR, OSO2CF3, OCOR, SR, NR2 or PR2 group wherein R is a linear or branched, cyclic or acyclic, C1-20 alkyl, C2-20 alkenyl, C2-20 alkynyl, C6-20 aryl, C7-20 alkylaryl or C7-20 arylalkyl radical; optionally containing heteroatoms belonging to groups 14-16. R is preferably a C1-6 alkyl, phenyl or benzyl group.
[0156] Most preferably each X is independently a hydrogen atom, a halogen atom, C1-6 alkoxy group or an R group, e.g. preferably a C1-6 alkyl, phenyl or benzyl group. Most preferably X is chlorine or a methyl radical. Preferably both X groups are the same.
[0157] L is preferably an alkylene linker or a bridge comprising a heteroatom, such as silicon or germanium, e.g. —SiR82—, wherein each R8 is independently C1-20 alkyl, C3-10 cycloakyl, C6-20 aryl or tri(C1-20 alkyl)silyl, such as trimethylsilyl. More preferably R8 is C1-6 alkyl, especially methyl or C3-7 cycloalkyl, such as cyclohexyl. Most preferably, L is a dimethylsilyl or a methylcyclohexylsilyl bridge (i.e. Me-Si-cyclohexyl). It may also be an ethylene bridge.
[0158] R2 and R2′ can be different but they are preferably the same. R2 and R2′ are preferably a C1-10 hydrocarbyl group such as C1-6 hydrocarbyl group. More preferably it is a linear or branched C1-10 alkyl group. More preferably it is a linear or branched C1-6 alkyl group, especially linear C1-6 alkyl group such as methyl or ethyl.
[0159] The R2 and R2′ groups can be interrupted by one or more heteroatoms, such as 1 or 2 heteroatoms, e.g. one heteroatom, selected from groups 14 to 16 of the periodic table. Such a heteroatom is preferably O, N or S, especially O. More preferably however the R2 and R2′ groups are free from heteroatoms. Most especially R2 and R2′ are methyl, especially both methyl.
[0160] The two Ar groups Ar and Ar′ can be the same or different. It is preferred however if the Ar groups are different. The Ar′ group may be unsubstituted. The Ar′ is preferably a phenyl based group optionally substituted by groups R1, especially an unsubstituted phenyl group.
[0161] The Ar group is preferably a C6-20 aryl group such as a phenyl group or naphthyl group. Whilst the Ar group can be a heteroaryl group, such as carbazolyl, it is preferable that Ar is not a heteroaryl group. The Ar group can be unsubstituted or substituted by one or more groups R1, more preferably by one or two R1 groups, especially in position 4 of the aryl ring bound to the indenyl ligand or in the 3,5-positions.
[0162] In one embodiment both Ar and Ar′ are unsubstituted. In another embodiment Ar′ is unsubstituted and Ar is substituted by one or two groups R1.
[0163] R1 is preferably a C1-20 hydrocarbyl group, such as a C1-20 alkyl group. R1 groups can be the same or different, preferably the same. More preferably, R1 is a C2-10 alkyl group such as C3-8 alkyl group. Highly preferred groups are tert butyl or isopropyl groups. It is preferred if the group R1 is bulky, i.e. is branched. Branching might be alpha or beta to the ring. Branched C3-8 alkyl groups are also favoured therefore.
[0164] In a further embodiment, two R1 groups on adjacent carbon atoms taken together can form a fused 5 or 6 membered non aromatic ring with the Ar group, said ring being itself optionally substituted with one or more groups R4. Such a ring might form a tetrahydroindenyl group with the Ar ring or a tetrahydronaphthyl group.
[0165] If an R4 group is present, there is preferably only 1 such group. It is preferably a C1-10 alkyl group.
[0166] It is preferred if there is one or two R1 groups present on the Ar group. Where there is one R1 group present, the group is preferably para to the indenyl ring (4-position). Where two R1 groups are present these are preferably at the 3 and 5 positions.
[0167] R5′ is preferably a C1-20 hydrocarbyl group containing one or more heteroatoms from groups 14-16 and optionally substituted by one or more halo atoms or R5′ is a C1-10 alkyl group, such as methyl but most preferably it is a group Z′R3′.
[0168] R6 and R6′ may be the same or different. In one preferred embodiment one of R6 and R6′ is hydrogen, especially R6. It is preferred if R6 and R6′ are not both hydrogen. If not hydrogen, it is preferred if each R6 and R6′ is preferably a C1-20 hydrocarbyl group, such as a C1-20 alkyl group or C6-10 aryl group. More preferably, R6 and R6′ are a C2-10 alkyl group such as C3-8 alkyl group. Highly preferred groups are tert-butyl groups. It is preferred if R6 and R6′ are bulky, i.e. are branched. Branching might be alpha or beta to the ring. Branched C3-8 alkyl groups are also favoured therefore.
[0169] The R7 and R7′ groups can be the same or different. Each R7 and R7′ group is preferably hydrogen, a C1-6 alkyl group or is a group ZR3. It is preferred if R7′ is hydrogen. It is preferred if R7 is hydrogen, C1-6 alkyl or ZR3. The combination of both R7 and R7′ being hydrogen is most preferred. It is also preferred if ZR3 represents OC1-6 alkyl, such as methoxy. It is also preferred is R7 represents C1-6 alkyl such as methyl.
[0170] Z and Z′ are O or S, preferably O.
[0171] R3 is preferably a C1-10 hydrocarbyl group, especially a C1-10 alkyl group, or aryl group optionally substituted by one or more halo groups. Most especially R3 is a C1-6 alkyl group, such as a linear C1-6 alkyl group, e.g. methyl or ethyl.
[0172] R3′ is preferably a C1-10 hydrocarbyl group, especially a C1-10 alkyl group, or aryl group optionally substituted by one or more halo groups. Most especially R3′ is a C1-6 alkyl group, such as a linear C1-6 alkyl group, e.g. methyl or ethyl or it is a phenyl based radical optionally substituted with one or more halo groups such as Ph or C6F5.
[0173] Thus, preferred complexes of the invention are of formula (II) or (II′)
[0174]
[0175] wherein
[0176] M is zirconium or hafnium;
[0177] each X is a sigma ligand, preferably each X is independently a hydrogen atom, a halogen atom, C1-6 alkoxy group, C1-6 alkyl, phenyl or benzyl group;
[0178] L is a divalent bridge selected from —R′2C—, —R′2C—CR′2—, —R′2Si—, —R′2Si—SiR′2—, —R′2Ge—, wherein each R′ is independently a hydrogen atom, C1-20 alkyl, C3-10 cycloalkyl, tri(C1-20-alkyl)silyl, C6-20-aryl, C7-20 arylalkyl or C7-20 alkylaryl;
[0179] each R2 or R2′ is a C1-10 alkyl group;
[0180] R5′ is a C1-10 alkyl group or Z′R3′ group;
[0181] R6 is hydrogen or a C1-10 alkyl group;
[0182] R6′ is a C1-10 alkyl group or C6-10 aryl group;
[0183] R7 is hydrogen, a C1-6 alkyl group or ZR3 group;
[0184] R7′ is hydrogen or a C1-10 alkyl group;
[0185] Z and Z′ are independently O or S;
[0186] R3′ is a C1-10 alkyl group, or a C6-10 aryl group optionally substituted by one or more halo groups;
[0187] R3 is a C1-10-alkyl group;
[0188] Each n is independently 0 to 4, e.g. 0, 1 or 2;
[0189] and each R1 is independently a C1-20 hydrocarbyl group, e.g. C1-10 alkyl group.
[0190] Further preferred complexes of the invention are those of formula (III) or (III′):
[0191]
[0192] wherein
[0193] M is zirconium or hafnium;
[0194] each X is a sigma ligand, preferably each X is independently a hydrogen atom, a halogen atom, C1-6 alkoxy group, C1-6 alkyl, phenyl or benzyl group;
[0195] L is a divalent bridge selected from —R′2C— or —R′2Si— wherein each R′ is independently a hydrogen atom, C1-20 alkyl or C3-10 cycloalkyl;
[0196] R6 is hydrogen or a C1-10 alkyl group;
[0197] R6′ is a C1-10 alkyl group or C6-10 aryl group;
[0198] R7 is hydrogen, C1-6 alkyl or OC1-6 alkyl;
[0199] Z′ is O or S;
[0200] R3′ is a C1-10 alkyl group, or C6-10 aryl group optionally substituted by one or more halo groups;
[0201] n is independently 0 to 4, e.g. 0, 1 or 2; and
[0202] each R1 is independently a C1-10 alkyl group.
[0203] Further preferred complexes of use in the invention are those of formula (IV) or (IV′):
[0204]
[0205] wherein
[0206] M is zirconium or hafnium;
[0207] each X is a sigma ligand, preferably each X is independently a hydrogen atom, a halogen atom, C1-6-alkoxy group, C1-6-alkyl, phenyl or benzyl group;
[0208] each R′ is independently a hydrogen atom, C1-20 alkyl or C3-7 cycloalkyl;
[0209] R6 is hydrogen or a C1-10 alkyl group;
[0210] R6′ is a C1-10 alkyl group or C6-10 aryl group;
[0211] R7 is hydrogen, C1-6 alkyl or OC1-6 alkyl;
[0212] Z′ is O or S;
[0213] R3′ is a C1-10 alkyl group, or C6-10 aryl group optionally substituted by one or more halo groups;
[0214] n is independently 0, 1 to 2; and
[0215] each R1 is independently a C3-8 alkyl group.
[0216] Most especially, the complex of use in the invention is of formula (V) or (V′):
[0217]
[0218] wherein
[0219] each X is a sigma ligand, preferably each X is independently a hydrogen atom, a halogen atom, C1-6-alkoxy group, C1-6-alkyl, phenyl or benzyl group;
[0220] R′ is independently a C1-6 alkyl or C3-10 cycloalkyl;
[0221] R1 is independently C3-8 alkyl;
[0222] R6 is hydrogen or a C3-8 alkyl group;
[0223] R6′ is a C3-8 alkyl group or C6-10 aryl group;
[0224] R3′ is a C1-6 alkyl group, or C6-10 aryl group optionally substituted by one or more halo groups; and
[0225] n is independently 0, 1 or 2.
[0226] Particular compounds of the invention include: rac-anti-Me2Si(2-Me-4-Ph-6-tBu-Ind)(2-Me-4-Ph-5-OMe-6-tBu-Ind)ZrCl2 rac-anti-Me2Si(2-Me-4-(p-tBuPh)-Ind)(2-Me-4-Ph-5-OMe-6-tBu-Ind)ZrCl2 rac-anti-Me2Si(2-Me-4-(3,5-di-tBuPh)-6-tBu-Ind)(2-Me-4-Ph-5-OMe-6-tBu-Ind)ZrCl2 rac-anti-Me2Si(2-Me-4-Ph-6-tBu-Ind)(2-Me-4,6-di-Ph-5-OMe-Ind)ZrCl2 rac-anti-Me2Si(2-Me-4-(p-tBuPh)-Ind)(2-Me-4-Ph-5-OC6F5)-6-iPr-Ind)ZrCl2 rac-anti-Me(CyHex)Si(2-Me-4-Ph-6-tBu-Ind)(2-Me-4-Ph-5-OMe-6-tBu-Ind)ZrCl2 rac-anti-Me2Si(2-Me-4-(3,5-di-tBuPh)-7-Me-Ind)(2-Me-4-Ph-5-OMe-6-tBu-Ind)ZrCl2 rac-anti-Me2Si(2-Me-4-(3,5-di-tBuPh)-7-OMe-Ind)(2-Me-4-Ph-5-OMe-6-tBu-Ind)ZrCl2 rac-anti-Me2Si(2-Me-4-(p-tBuPh)-6-tBu-Ind)(2-Me-4-Ph-5-OMe-6-tBu-Ind)ZrCl2 rac-anti-Me2Si(2-Me-4-(p-tBuPh)-Ind)(2-Me-4-(4-tBuPh)-5-OMe-6-tBu-Ind)ZrCl2 rac-anti-Me2Si(2-Me-4-(p-tBuPh)-Ind)(2-Me-4-(3,5-tBu2Ph)-5-OMe-6-tBu-Ind)ZrCl2 rac-anti-Me2Si(2-Me-4-(p-tBuPh)-Ind)(2-Me-4-Ph-5-OiBu-6-tBu-Ind)ZrCl2
[0227] For the avoidance of doubt, any narrower definition of a substituent offered above can be combined with any other broad or narrowed definition of any other substituent.
[0228] Throughout the disclosure above, where a narrower definition of a substituent is presented, that narrower definition is deemed disclosed in conjunction with all broader and narrower definitions of other substituents in the application.
[0229] In one especially preferred embodiment the complex is rac-anti-Me2Si(2-Me-4-(p-tBuPh)-Ind)(2-Me-4-Ph-5-OMe-6-tBu-Ind)ZrCl2.
[0230] Concerning the synthesis of the complex according to this invention it is also referred to WO 2013/007650 A1.
[0231] To form an active catalytic species it is normally necessary to employ a cocatalyst as is well known in the art. Cocatalysts comprising one or more compounds of Group 13 metals, like organoaluminium compounds or borates used to activate metallocene catalysts are suitable for use in this invention.
[0232] Thus the catalyst according to this invention comprises (i) a complex as defined above and (ii) a cocatalyst, like an aluminium alkyl compound (or other appropriate cocatalyst), or the reaction product thereof. Thus the cocatalyst is preferably an alumoxane, like MAO or an alumoxane other than MAO.
[0233] Borate cocatalysts can also be employed. It will be appreciated by the skilled man that where boron based cocatalysts are employed, it is normal to preactivate the complex by reaction thereof with an aluminium alkyl compound, such as TIBA. This procedure is well known and any suitable aluminium alkyl, e.g. Al(C1-6-alkyl)3, can be used.
[0234] Boron based cocatalysts of interest include those of formula
BY3
BY3
[0235] wherein Y is the same or different and is a hydrogen atom, an alkyl group of from 1 to about 20 carbon atoms, an aryl group of from 6 to about 15 carbon atoms, alkylaryl, arylalkyl, haloalkyl or haloaryl each having from 1 to 10 carbon atoms in the alkyl radical and from 6-20 carbon atoms in the aryl radical or fluorine, chlorine, bromine or iodine. Preferred examples for Y are trifluoromethyl, p-fluorophenyl, 3,5-difluorophenyl, pentafluorophenyl, 3,4,5-trifluorophenyl and 3,5-di(trifluoromethyl)phenyl. Preferred options are trifluoroborane, tris(4-fluorophenyl)borane, tris(3,5-difluorophenyl)borane, tris(4-fluoromethylphenyl)borane, tris(2,4,6-trifluorophenyl)borane, tris(penta-fluorophenyl)borane, tris(3,5-difluorophenyl)borane and/or tris(3,4,5-trifluorophenyl)borane.
[0236] Particular preference is given to tris(pentafluorophenyl)borane.
[0237] It is preferred however is borates are used, i.e. compounds of general formula [C]+[BX4]−. Such ionic cocatalysts contain a non-coordinating anion [BX4]− such as tetrakis(pentafluorophenyl)borate. Suitable counterions [C]+ are protonated amine or aniline derivatives such as methylammonium, anilinium, dimethylammonium, diethylammonium, N-methylanilinium, diphenylammonium, N,N-dimethylanilinium, trimethylammonium, triethylammonium, tri-n-butylammonium, methyldiphenylammonium, pyridinium, p-bromo-N,N-dimethylanilinium or p-nitro-N,N-dimethylanilinium.
[0238] Preferred ionic compounds which can be used according to the present invention include: tributylammoniumtetrakis(pentafluorophenyl)borate, tributylammoniumtetrakis(trifluoromethylphenyl)borate, tributylammoniumtetrakis(4-fluorophenyl)borate, N,N-dimethylcyclohexylammoniumtetrakis(pentafluorophenyl)borate, N,N-dime thylbenzylammoniumtetrakis(pentafluorophenyl)borate, N,N-dimethylaniliniumtetrakis(pentafluorophenyl)borate, N,N-di(propyl)ammoniumtetrakis(pentafluorophenyl)borate, di(cyclohexyl)ammoniumtetrakist(pentafluorophenyl)borate, triphenylcarbeniumtetrakis(pentafluorophenyl)borate, or ferroceniumtetrakis(pentafluorophenyl)borate. Preference is given to triphenylcarbeniumtetrakis(pentafluorophenyl)borate, N,N-dimethylcyclohexylammoniumtetrakis(pentafluorophenyl)borate or N,N-dimethylbenzylammoniumtetrakis(pentafluorophenyl)borate.
[0239] The use of B(C6F5)3, C6H5N(CH3)2H:B(C6F5)4, (C6H5)3C:B(C6F5)4 is especially preferred.
[0240] The metallocene complex of the present invention can be used in combination with a suitable cocatalyst as a catalyst e.g. in a solvent such as toluene or an aliphatic hydrocarbon, (i.e. for polymerization in solution), as it is well known in the art. Preferably, polymerization takes place in the condensed phase or in gas phase.
[0241] The catalyst of the invention can be used in supported or unsupported form. The particulate support material used is preferably an organic or inorganic material, such as silica, alumina or zirconia or a mixed oxide such as silica-alumina, in particular silica, alumina or silica-alumina. The use of a silica support is preferred. The skilled man is aware of the procedures required to support a metallocene catalyst.
[0242] Especially preferably the support is a porous material so that the complex may be loaded into the pores of the support, e.g. using a process analogous to those described in WO94/14856, WO95/12622 and WO2006/097497. The particle size is not critical but is preferably in the range 5 to 200 μm, more preferably 20 to 80 μm. The use of these supports is routine in the art.
[0243] In preferred embodiment, no support is used at all. Such a catalyst can be prepared in solution, for example in an aromatic solvent like toluene, by contacting the metallocene (as a solid or as a solution) with the cocatalyst, for example methylaluminoxane or a borane or a borate salt, or can be prepared by sequentially adding the catalyst components to the polymerization medium. In a preferred embodiment, the metallocene (when X differs from alkyl or hydrogen) is prereacted with an aluminum alkyl, in a ratio metal/aluminum of from 1:1 up to 1:500, preferably from 1:1 up to 1:250, and then combined with the borane or borate cocatalyst, either in a separate vessel or directly into the polymerization reactor. Preferred metal/boron ratios are between 1:1 and 1:100, more preferably 1:1 to 1:10.
[0244] In one particularly preferred embodiment, no external carrier is used but the catalyst is still presented in solid particulate form. Thus no external support material such as inert organic or inorganic carrier, such as for example silica as described above is employed.
[0245] In order to provide the catalyst of the invention in solid form but without using an external carrier, it is preferred if a liquid/liquid emulsion system is used. The process involves forming dispersing catalyst components (i) and (ii), i.e. the complex and the cocatalyst, in a solvent, and solidifying said dispersed droplets to form solid particles.
[0246] Reference is made to WO2006/069733 describing principles of such a continuous or semicontinuous preparation methods of the solid catalyst types, prepared via emulsion/solidification method. For further details it is also referred to WO 2013/007650 A1.
[0247] According to a further aspect, the present invention relates to the use of the polypropylene composition as described above for preparing a molded article, such as an injection-molded article or an extrusion-molded article.
[0248] The present invention will now be described in further detail by the following Examples.
EXAMPLES
1. Measuring Methods
[0249] The following definitions of terms and determination methods apply for the above general description of the invention as well as to the below examples unless otherwise defined. Calculation of comonomer content of the propylene copolymer fraction (CF2):
[0250]
[0251] wherein
- [0252] w(P1) is the weight fraction [in wt.-%] of the propylene copolymer fraction (CF1) based on the weight of the propylene copolymer (C),
- [0253] w(P2) is the weight fraction [in wt.-%] of propylene copolymer fraction (CF2) based on the weight of the propylene copolymer (C),
- [0254] C(P1) is the comonomer content [in mol-%] of the propylene copolymer fraction (CF1),
- [0255] C(P1+P2) is the comonomer content [in mol-%] of the propylene copolymer (C),
- [0256] C(P2) is the calculated comonomer content [in mol-%] of the propylene copolymer fraction (CF2).
[0257] Calculation of melt flow rate MFR2 (230° C.) of the propylene copolymer fraction (CF2):
[0258]
[0259] wherein
- [0260] w(P1) is the weight fraction [in wt.-%] of the propylene copolymer fraction (CF1) based on the weight of the propylene copolymer (C),
- [0261] w(P2) is the weight fraction [in wt.-%] of the propylene copolymer fraction (CF2) based on the weight of the propylene copolymer (C),
- [0262] MFR(P1) is the melt flow rate MFR2 (230° C.) [in g/10 min] of the propylene copolymer fraction (CF1),
- [0263] MFR(P1+P2) is the melt flow rate MFR2 (230° C.) [in g/10 min] of the propylene copolymer (C),
- [0264] MFR(P2) is the calculated melt flow rate MFR2 (230° C.) [in g/10 min] of the propylene copolymer fraction (CF2).
[0265] Identical approach is used in case the propylene copolymer (C) consists of a propylene homopolymer fraction (HF1) (wherein (CF1) is replaced by (HF1)) and a propylene copolymer fraction (CF1′) (wherein (CF2) is replaced by (CF1′)).
[0266] Calculation of comonomer content of the elastomeric copolymer (E), e.g. of the terpolymer (T):
[0267]
[0268] wherein
- [0269] w(P1) is the weight fraction [in wt.-%] of the propylene copolymer (C) based on the weight of the polypropylene composition,
- [0270] w(P2) is the weight fraction [in wt.-%] of the elastomeric copolymer (E) based on the weight of the polypropylene composition,
- [0271] C(P1) is the comonomer content [in mol-%] of the propylene copolymer (C),
- [0272] C(P1+P2) is the comonomer content [in mol-%] of the polypropylene composition,
- [0273] C(P2) is the calculated comonomer content [in mol-%] of the elastomeric copolymer (E).
[0274] Quantification of Polymer Microstructure by NMR Spectroscopy
[0275] Quantitative nuclear-magnetic resonance (NMR) spectroscopy was used to quantify the comonomer content of the polymers.
[0276] Quantitative 13C{1H} NMR spectra recorded in the molten-state using a Bruker Advance III 500 NMR spectrometer operating at 500.13 and 125.76 MHz for 1H and 13C respectively. All spectra were recorded using a 13C optimised 7 mm magic-angle spinning (MAS) probehead at 180° C. using nitrogen gas for all pneumatics. Approximately 200 mg of material was packed into a 7 mm outer diameter zirconia MAS rotor and spun at 4 kHz. This setup was chosen primarily for the high sensitivity needed for rapid identification and accurate quantification {Klimke, K., Parkinson, M., Piel, C., Kaminsky, W., Spiess, H. W., Wilhelm, M., Macromol. Chem. Phys. 2006; 207:382; Parkinson, M., Klimke, K., Spiess, H. W., Wilhelm, M., Macromol. Chem. Phys. 2007; 208:2128; Castignolles, P., Graf, R., Parkinson, M., Wilhelm, M., Gaborieau, M., Polymer 2009, 50, 2373}. Standard single-pulse excitation was employed utilising the NOE at short recycle delays {Pollard, M., Klimke, K., Graf, R., Spiess, H. W., Wilhelm, M., Sperber, O., Piel, C., Kaminsky, W., Macromolecules 2004, 37, 813; Klimke, K., Parkinson, M., Piel, C., Kaminsky, W., Spiess, H. W., Wilhelm, M., Macromol. Chem. Phys. 2006, 207, 382} and the RS-HEPT decoupling scheme {Filip, X., Tripon, C., Filip, C., J. Mag. Resn. 2005, 176, 239; Griffin, J. M., Tripon, C., Samoson, A., Filip, C., and Brown, S. P., Mag. Res. in Chem. 2007 45, S1, S198}. A total of 1024 (1 k) transients were acquired per spectra.
[0277] Quantitative 13C{1H} NMR spectra were processed, integrated and relevant quantitative properties determined from the integrals. All chemical shifts are internally referenced to the methyl isotactic pentad (mmmm) at 21.85 ppm.
[0278] The tacticity distribution was quantified through integration of the methyl region in the 13C{1H} spectra correcting for any sites not related to the stereo sequences of interest. {Busico, V., Cipullo, R., Prog. Polym. Sci. 2001, 26, 443; Busico, V., Cipullo, R., Monaco, G., Vacatello, M., Segre, A. L., Macromoleucles 1997, 30, 6251}.
[0279] The influence of regio defects on the quantification of the tacticity distribution was corrected for by subtraction of representative regio defect integrals from specific integrals of the stereo sequences.
[0280] The influence of comonomer on the quantification of the tacticity distribution was corrected for by subtraction of representative comonomer integrals from specific integrals of the stereo sequences.
[0281] The isotacticity was determined at the triad level and reported as the percentage of isotactic triad (mm) with respect to all triad sequences:
mm[%]=100*(mm/sum of all triads)
mm[%]=100*(mm/sum of all triads)
[0282] where mr represents the sum of the reversible mr and rm triad sequences.
[0283] Characteristic signals indicative of regio defects were observed {Resconi, L., Cavallo, L., Fait, A., Piemontesi, F., Chem. Rev. 2000, 100, 1253}.
[0284] The presence of 2,1-erythro regio defects was indicated by the presence of the Pαβ and Pαγ methyl sites at 17.7 and 17.2 ppm and confirmed by other characteristic signals.
[0285] The amount of 2,1-erythro regio defects was quantified using the average integral of the Pαβ and Pαγ sites at 17.7 and 17.2 ppm:
P21e=0.5*(Ie6+Ie8)
P21e=0.5*(Ie6+Ie8)
[0286] The presence of ethylene incorporated directly after a secondary inserted propene (E21) was indicated by the presence of the Sαβδ, Sαβγ and Tγγ sites at 34.9, 34.5 and 33.8 ppm and confirmed by other characteristic signals.
[0287] The amount ethylene incorporated directly after a secondary inserted propene was quantified using the integral of the Tγγ site at 33.8 ppm:
E21=ITTγγ
E21=ITTγγ
[0288] The total amount of secondary (2,1) inserted propene was quantified as the sum of all units containing secondary inserted propene:
P21=P21e+E21
P21=P21e+E21
[0289] Characteristic signals corresponding to other regio defects were not observed {Resconi, L., Cavallo, L., Fait, A., Piemontesi, F., Chem. Rev. 2000, 100, 1253}.
[0290] The total amount of primary (1,2) inserted propene was quantified based on the propene methyl sites between 23.6 and 19.7 ppm with correction for any included sites not related to primary insertion:
P12=ICH3+P21e
P12=ICH3+P21e
[0291] The total amount of propene was quantified as the sum of primary (1,2) inserted propene and all regio defects:
Ptotal=P12+P21
Ptotal=P12+P21
[0292] The mole percent of 2,1-erythro regio defects was quantified with respect to all propene:
[21e]mol %=100*(P21e/Ptotal)
[21e]mol %=100*(P21e/Ptotal)
[0293] Characteristic signals corresponding to the incorporation of 1-hexene were observed and the comonomer fraction calculated as the fraction of 1-hexene in the polymer with respect to all monomer in the polymer:
fHtotal=Htotal/(Etotal+Ptotal+Htotal))
fHtotal=Htotal/(Etotal+Ptotal+Htotal))
[0294] The amount isolated 1-hexene incorporated in PPHPP sequences was quantified using the integral of the αB4 sites at 44.1 ppm accounting for the number of reporting sites per comonomer and the presence of consecutively incorporated 1-hexene in PPHHPP sequences:
H=(IαB4/2)−(HH/2)
H=(IαB4/2)−(HH/2)
[0295] The amount consecutively incorporated 1-hexene in PPHHPP sequences was quantified using the integral of the ααB4B4 site at 41.6 ppm accounting for the number of reporting sites per comonomer:
HH=2*IααB4B4
HH=2*IααB4B4
[0296] The total 1-hexene content was calculated based on the sum of isolated and consecutively incorporated 1-hexene:
Htotal=H+HH
Htotal=H+HH
[0297] Characteristic signals corresponding to the incorporation of ethylene were observed and the comonomer fraction calculated as the fraction of ethylene in the polymer with respect to all monomer in the polymer:
fEtotal=Etotal/(Etotal+Ptotal+Htotal)
fEtotal=Etotal/(Etotal+Ptotal+Htotal)
[0298] The amount isolated and non-consecutive ethylene incorporated in PPEPP and PPEPEPP sequences respectively was quantified using the integral of the Sββ sites at 24.5 ppm accounting for the number of reporting sites per comonomer:
E=ISββ
E=ISββ
[0299] The presence of non-consecutive ethylene incorporation in PPEPEPP sequences was indicated by the presence of the Tδδ site at 33.1 ppm and confirmed by other characteristic signals.
[0300] The amount double consecutively incorporated ethylene in PPEEPP sequences was quantified using the integral of the Sβδ site at 27.1 ppm accounting for the number of reporting sites per comonomer:
EE=ISβδ
EE=ISβδ
[0301] The amount triple or longer consecutively incorporated ethylene in PP(E)nPP sequences was quantified using the integral of the Sδδ and Sγδ sites at 29.6 and 30.1 ppm accounting for the number of reporting sites per comonomer:
EEE=(ISδδ/2)+(ISγδ/4)
EEE=(ISδδ/2)+(ISγδ/4)
[0302] The total ethylene content was calculated based on the sum of isolated, consecutively incorporated ethylene and ethylene incorporated directly after a secondary inserted propene:
Etotal=E+EE+EEE+E21
Etotal=E+EE+EEE+E21
[0303] The mole percent comonomer incorporation is calculated from the mole fraction:
H[mol %]=100*fHtotal
E[mol %]=100*fEtotal
H[mol %]=100*fHtotal
E[mol %]=100*fEtotal
[0304] The weight percent comonomer incorporation is calculated from the mole fraction:
H[wt %]=100*(fHtotal*84.16)/((fEtotal*28.05)+(fHtotal*84.16)+((1−(fEtotal+fHtotal))*42.08))
E[wt %]=100*(fEtotal*28.05)/((fEtotal*28.05)+(fHtotal*84.16)+((1−(fEtotal+fHtotal))*42.08))
H[wt %]=100*(fHtotal*84.16)/((fEtotal*28.05)+(fHtotal*84.16)+((1−(fEtotal+fHtotal))*42.08))
E[wt %]=100*(fEtotal*28.05)/((fEtotal*28.05)+(fHtotal*84.16)+((1−(fEtotal+fHtotal))*42.08))
[0305] MFR2 (230° C.) is measured according to ISO 1133-1 (230° C., 2.16 kg load).
[0306] The xylene solubles (XCS, wt.-%): Content of xylene cold solubles (XCS) is determined at 25° C. according ISO 16152; first edition; 2005-07-01.
[0307] Intrinsic viscosity is measured according to DIN ISO 1628/1, October 1999 (in Decalin at 135° C.).
[0308] DSC analysis, melting temperature (Tm) and heat of fusion (Hf), crystallization temperature (Tc) and heat of crystallization (Hc) measured with a TA Instrument Q200 differential scanning calorimetry (DSC) on 5 to 7 mg samples. DSC is run according to ISO 11357/part 3/method C2 in a heat/cool/heat cycle with a scan rate of 10° C./min in the temperature range of −30 to +225° C. Crystallization temperature and heat of crystallization (Hc) are determined from the cooling step, while melting temperature and heat of fusion (Hf) are determined from the second heating step.
[0309] The glass transition temperature Tg is determined by dynamic mechanical analysis according to ISO 6721-7. The measurements are done in torsion mode on compression moulded samples (40×10×1 mm3) between −100° C. and +150° C. with a heating rate of 2° C./min and a frequency of 1 Hz.
[0310] Tensile Modulus was measured according to ISO 527-2 (cross head speed=1 mm/min; 23° C.) using injection molded specimens as described in EN ISO 1873-2 (dog bone shape, 4 mm thickness).
[0311] The Charpy notched impact strength (Charpy NIS) was measured according to ISO 179 1 eA at −20° C., using injection molded bar test specimens of 80×10×4 mm3 mm3 prepared in accordance with ISO 294-1:1996
[0312] Brittle-to-Ductile Transition Temperature
[0313] The determination of the brittle-to-ductile transition temperature (BDTT) is based on the a(cN) values as determined from Charpy instrumented impact strength according to ISO 179-2:2000 on V-notched specimen with a geometry of 80×10×4 mm3 as required in ISO 179-1 eA.
[0314] The a(cN) values are determined in intervals of 3° C. from −40° C. to +41° C. with an impact velocity of 1.5 m/s and plotted over temperature, calculating the BDTT as the average value of the step increase. For a detailed description of the determination of the BDTT reference is made to Grein, C. et al, Impact Modified Isotactic Polypropylene with Controlled Rubber Intrinsic Viscosities: Some New Aspects About Morphology and Fracture, J Appl Polymer Sci, 87 (2003), 1702-1712.
2. Examples
[0315] The catalyst has been prepared following the procedure described in WO 2013/007650 A1 for catalyst E2, by adjusting the metallocene and MAO amounts in order to achieve the Al/Zr ratio indicated in table 1. The catalyst has been off-line prepolymerized with propylene, following the procedure described in the above document for catalyst E2P.
[0316]
| TABLE 1 | ||||
|---|---|---|---|---|
| Catalyst | ||||
| DofP1 | Al/Zr2 | MC3 | ||
| cat. | Metallocene | [g/g] | [mol/mol] | [wt.-%] |
| Cat | MC1* | 1.8 | 267 | 1.69 |
| *rac-anti-Me2Si(2-Me-4-(p-tBuPh)-Ind)(2-Me-4-Ph-5-OMe-6-tBu-Ind)ZrCl2 | ||||
| 1Degree of off-line pre-polymerisation | ||||
| 2Al/Zr molar ratio in catalyst | ||||
| 3MC content of off-line prepolymerised catalyst | ||||
Comparative Example CE1
Step 1: Prepolymerization+Bulk
[0317] A stirred autoclave (double helix stirrer) with a volume of 21.2 dm3 containing 0.2 bar-g propylene is filled with additional 3.97 kg propylene. After adding 0.73 mmol triethylaluminium (Aldrich, 1 molar solution in n-hexane) using a stream of 250 g propylene, the solution is stirred at 20° C. and 250 rpm for 20 min, then the reactor is brought up to the set prepolymerization temperature (HB-Therm) and the catalyst is injected as described in the following. The solid, pre-polymerized catalyst (amount as listed in Table 2) is loaded into a 5-mL stainless steel vial inside the glovebox, the vial is attached to the autoclave, then a second 5-mL vial containing 4 ml n-hexane and pressurized with 10 bars of N2 is added on top, the valve between the two vials is opened and the solid catalyst is contacted with hexane under N2 pressure for 2 s, then flushed into the reactor with 250 g propylene. Stirring speed is increased to 250 rpm and prepolymerisation is run for the set time. At the end of the prepolymerization step the stirring speed is increased to 250 rpm and the reactor temperature raised to 80° C. When the internal reactor temperature reaches 71° C., the desired H2 amount is added with a defined flow via thermal mass flow controller. The reactor temperature is held constant throughout the polymerization time. The polymerization time is measured starting when the temperature is 2° C. below the set polymerization temperature.
Step 2: Gas Phase
[0318] After the bulk step is finished, the stirrer speed is reduced to 50 rpm and the reactor pressure reduced to 24.5 bar-g by venting. Afterwards the stirrer speed is set to 180 rpm, the reactor temperature to 85° C. and the chosen amount of 1-hexene is dosed via mass flow controllers (MFC) with a flow of 15 g/min. Then the reactor P and T are held constant by feeding via MFC a given ratio of C3/C6 at 25 bar-g and 85° C. for the time needed to reach the target split. Then the reaction is stopped by setting the stirrer speed to 20 rpm, cooling the reactor down to 30° C., flashing the volatile components.
[0319] After flushing the reactor twice with N2 and one vacuum/N2 cycle, the product is taken out and dried overnight in a hood. 100 g of the polymer is additivated with 0.2 wt % Ionol and 0.1 wt % PEPQ (dissolved in acetone) and dried also overnight in a hood+2 hours in a vacuum drying oven at 60° C.
Comparative Examples CE2, CE3 and Inventive Examples IE1, IE2, IE3, IE4
Step 1: Prepoly+Bulk See CE1
Step 2: Gas Phase 1
[0320] After the bulk step is finished, the stirrer speed is reduced to 50 rpm and the reactor pressure reduced to 24.5 bar-g by venting. Afterwards the stirrer speed is set to 180 rpm, the reactor temperature to 85° C. and the chosen amount of 1-hexene is dosed via MFC with a flow of 15 g/min. Then the reactor P and T are held constant by feeding via MFC a given ratio of C3/C6 at 25 bar-g and 85° C. for the time required to reach the target split.
Step 3: Gas Phase 2
[0321] After the bulk+gas step 1 has finished, the temperature control device was set to 70° C. and the stirrer speed is reduced to 50 rpm. The reactor pressure is then reduced to 0.3 bar-g by venting, the stirrer speed is adjusted to 180 rpm and the reactor T to the target value. Then the reactor filling is started by feeding a defined ratio of C3/C2 monomer gas. This ratio depends on the relative comonomer reactivity ratio (R C2/C3) of the given catalyst system and the desired copolymer composition. The speed of the reactor filling during the transition is limited by the max. flow of the gas flow controllers. When the reactor temperature reaches 1° below the target temperature and the pressure has reached the desired value, the composition of the dosed C3/C2 mixture is changed to match the desired polymer composition and both temperature and pressure are held constant as long as the amount of C3/C2 gas mixture required to reach the target split of rubber to matrix has been consumed. The reaction is stopped by setting the stirrer speed to 20 rpm, cooling the reactor to 30° C. and flashing the volatile components.
[0322] After flushing the reactor twice with N2 and one vacuum/N2 cycle, the product is taken out and dried overnight in a hood. 100 g of the polymer is additivated with 0.2 wt % Ionol and 0.1 wt % PEPQ (dissolved in acetone) and dried also overnight in a hood+2 hours in a vacuum drying oven at 60° C.
[0323] Specific polymerisation process parameters for the comparative and inventive examples are shown in table 2a and 2b.
[0324]
| TABLE 2a | ||||
|---|---|---|---|---|
| Polymerization and Properties of the comparative examples | ||||
| Parameter | unit | CE1 | CE2 | CE3 |
| Prepolymerisation | ||||
| temperature | [° C.] | 20 | 20 | 20 |
| residence time | [min] | 10 | 10 | 10 |
| prepolymerized cat. amount | [mg] | 138 | 138 | 138 |
| Loop | ||||
| temperature | [° C.] | 80 | 80 | 80 |
| pressure | [bar-g] | 55 | 55 | 55 |
| residence time | [min] | 30 | 30 | 30 |
| C3 total | [g] | 4429 | 4423 | 4429 |
| H2 total | [nl] | 2.8 | 2.8 | 1.8 |
| yield | [g] | 515 | 565 | 597 |
| C2 | [mol-%] | 0 | 0 | 0 |
| C6 | [mol-%] | 0 | 0 | 0 |
| Split | [wt.-%] | 52 | 32 | 34 |
| GPR1 | ||||
| temperature | [° C.] | 85 | 85 | 85 |
| pressure | [bar-g] | 25 | 25 | 25 |
| residence time | [min] | 62 | 51 | 60 |
| H2 feed | [nl] | 0 | 0 | 0 |
| C3 feed during transition | [g] | 1050 | 1050 | 1050 |
| C3 feed during polymerization | [g] | 430 | 430 | 430 |
| C6 feed during transition | [g] | 49 | 50 | 50 |
| C6 feed during polymerization | [g] | 38 | 40 | 38 |
| yield | [g] | 468 | 470 | 468 |
| C2 total | [mol-%] | 0 | 0 | 0 |
| C6 total | [mol-%] | 2.3 | 1.1 | 1.2 |
| C6* | [mol-%] | 4.6 | 3.7 | 4.4 |
| XCS | [wt.-%] | 26.6 | 27.1 | 28 |
| MFR | [g/10 min] | 28.5 | ||
| IV | [dl/g] | 1.5 | ||
| Split | [wt.-%] | 48 | 27 | 26 |
| GPR2 | ||||
| temperature | [° C.] | 70 | 70 | |
| pressure | [bar-g] | 19.6 | 19.7 | |
| residence time | [min] | 63 | 46 | |
| H2 feed | [nl] | 0 | 0 | |
| C3 feed during transition | [g] | 483 | 483 | |
| C3 feed during polymerization | [g] | 648 | 640 | |
| C2 feed during transition | [g] | 155 | 155 | |
| C2 feed during polymerization | [g] | 71 | 70 | |
| yield | [g] | 719 | 710 | |
| C2 | [mol-%] | 8 | 8 | |
| C6 | [mol-%] | 1.1 | 1.2 | |
| C2′ | [mol-%] | 19.5 | 20.0 | |
| C6** | [mol-%] | 0.24 | 0.15 | |
| XCS | [wt.-%] | 57.0 | 56.8 | |
| C2 in XCS | [mol-%] | 13.3 | 13.9 | |
| C6 in XCS | [mol-%] | 5.9 | 1.2 | 0.7 |
| MFR | [g/10 min] | 7.7 | 5.5 | |
| IV | [dl/g] | 1.85 | 2.04 | |
| IV of XCS | [dl/g] | 2.3 | 2.2 | |
| Split | [wt.-%] | 41 | 40 | |
[0325]
| TABLE 2b | |||||
|---|---|---|---|---|---|
| Polymerization and Properties of the inventive examples | |||||
| Parameter | unit | IE1 | IE2 | IE3 | IE4 |
| Prepolymerisation | |||||
| temperature | [° C.] | 20 | 20 | 20 | 20 |
| residence time | [min] | 10 | 10 | 10 | 10 |
| prepolymerized cat. | [mg] | 142 | 182 | 139 | 140 |
| amount | |||||
| Loop | |||||
| temperature | [° C.] | 80 | 80 | 80 | 80 |
| pressure | [bar-g] | 55 | 55 | 55 | 55 |
| residence time | [min] | 30 | 30 | 30 | 36.5 |
| C3 total | [g] | 4425 | 4436 | 4429 | 4429 |
| H2 total | [nl] | 2.8 | 2.8 | 1.8 | 1.8 |
| yield | [g] | 531 | 772 | 598 | 792 |
| C2 | [mol-%] | 0 | 0 | 0 | 0 |
| C6 | [mol-%] | 0 | 0 | 0 | 0 |
| Split | [wt.-%] | 31 | 37 | 38 | 39 |
| GPR1 | |||||
| temperature | [° C.] | 85 | 85 | 85 | 85 |
| pressure | [bar-g] | 25 | 25 | 25 | 25 |
| residence time | [min] | 62 | 51 | 60 | 69 |
| H2 feed | [nl] | 0 | 0 | 0 | 0 |
| C3 feed during | [g] | 1050 | 1000 | 1050 | 1050 |
| transition | |||||
| C3 feed during | [g] | 440 | 500 | 224 | 336 |
| polymerization | |||||
| C6 feed during | [g] | 50 | 50 | 50 | 48 |
| transition | |||||
| C6 feed during | [g] | 36 | 45 | 21 | 29 |
| polymerization | |||||
| yield | [g] | 476 | 545 | 245 | 365 |
| C2 total | [mol-%] | 0 | 0 | 0 | 0 |
| C6 total | [mol-%] | 1.7 | 1.6 | 1.3 | 0.9 |
| C6* | [mol-%] | 3.5 | 3.9 | 4.3 | 2.8 |
| XCS | [wt.-%] | 32.7 | 23.8 | 15.6 | 16.0 |
| Split | [wt.-%] | 28 | 26 | 16 | 18 |
| GPR2 | |||||
| temperature | [° C.] | 70 | 70 | 70 | 70 |
| pressure | [bar-g] | 20 | 19.8 | 20 | 20 |
| residence time | [min] | 55 | 68 | 131 | 123 |
| H2 feed | [nl] | 0 | 0 | 0 | 0 |
| C3 feed during | [g] | 321 | 227 | 328 | 252 |
| transition | |||||
| C3 feed during | [g] | 568 | 549 | 569 | 625 |
| polymerization | |||||
| C2 feed during | [g] | 238 | 285 | 244 | 271 |
| transition | |||||
| C2 feed during | [g] | 139 | 234 | 142 | 268 |
| polymerization | |||||
| yield | [g] | 707 | 783 | 711 | 893 |
| C2 total | [mol-%] | 15.7 | 19.0 | 15.0 | 19.7 |
| C6 total | [mol-%] | 1.1 | 1.1 | 0.8 | 0.6 |
| C2′ | [mol-%] | 38.3 | 51.4 | 32.6 | 45.8 |
| C6** | [mol-%] | 0.24 | 0.25 | 0.21 | 0.20 |
| XCS | [wt.-%] | 60.3 | 52.0 | 54.4 | 52.1 |
| C2 in XCS | [mol-%] | 25.7 | 36.3 | 26.6 | 36.1 |
| C6 in XCS | [mol-%] | 0.9 | 0.9 | 0.8 | 0.5 |
| MFR | [g/10 min] | 15.5 | 15.6 | 4.9 | 6.1 |
| IV | [dl/g] | 1.61 | 1.72 | 1.94 | 1.85 |
| IV of XCS | [dl/g] | 1.7 | 1.8 | 2.0 | 1.6 |
| Split | [wt.-%] | 41 | 37 | 46 | 43 |
| ′is the C2 content of the polymer produced in the GPR2 | |||||
| *is the C6 content of the polymer produced in the GPR1 | |||||
| **is the C6 content of the polymer produced in the GPR2 | |||||
[0326]
| TABLE 3 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Properties of the examples | ||||||||
| Parameter | unit | CE1 | CE2 | CE3 | IE1 | IE2 | IE3 | IE4 |
| Tg [° C.] | [° C.] | — | −16 | −16.6 | −35.2 | −44.1 | −34.9 | −41.9 |
| NIS | [kJ/m2] | 1.1 | 1.5 | 1.6 | 80 | 51 | 80 | 81 |
| (−19° C.) | ||||||||
| DBTT | [° C.] | 51 | 2 | 4 | −26 | −31 | −29 | −35 |
| Tm | [° C.] | 147 | 142 | 147 | 142 | 143 | 145 | 144 |
| Tc | [° C.] | 104 | 107 | 104 | 106 | 106 | 107 | 109 |
| TM | [MPa] | 767 | 363 | 327 | 264 | 402 | 292 | 375 |
| Tg glass transition temperature of the amorphous phase | ||||||||
| NIS (−19° C.) Notched Impact Strength at −19° C. | ||||||||
| DBTT Ductile to brittle transition temperature | ||||||||
| Tm melting temperature | ||||||||
| Tc crystallization temperature | ||||||||
| TM Tensile Modulus | ||||||||
Claims
The invention claimed is:
1. A polypropylene composition comprising comonomer units derived from ethylene in an amount of from 9.0 to 52.0 mol-% and comonomer units derived from at least one C5-12 α-olefin in an amount of from 0.4 to 3.0 mol-%, wherein the polypropylene composition
(a) has an amount of xylene cold solubles (XCS) of at least 30 wt.-%,
(b) fulfills in-equation (I)
IV(XCS)−IV(tot)≦0.30 (I)
IV(XCS)−IV(tot)≦0.30 (I)
wherein IV(XCS) is the intrinsic viscosity (IV) of the xylene cold soluble (XCS) fraction of the polypropylene composition, and IV(tot) is the intrinsic viscosity (IV) of the polypropylene composition, and
(c) is a heterophasic propylene copolymer (HECO) comprising a propylene copolymer (C) and an elastomeric copolymer (E), wherein the propylene copolymer (C) is a propylene copolymer of units derived from propylene and at least one C5-12 α-olefin and the elastomeric copolymer (E) is a terpolymer (T) of units derived from propylene ethylene and C5-12 α-olefin.
2. The polypropylene composition according to claim 1, wherein the xylene cold soluble (XCS) fraction has an amount (a) of ethylene-derived comonomer units of from 20.0 to 80.0 mol-%; and/or (b) of C5-12 α-olefin-derived comonomer units of from 0.1 to 1.5 mol-%.
3. A polypropylene composition comprising comonomer units derived from ethylene in an amount of from 9.0 to 52.0 mol-% and comonomer units derived from at least one C5-12 α-olefin in an amount of from 0.4 to 3.0 mol-%, wherein the polypropylene composition has an amount of xylene cold solubles (XCS) of at least 30 wt.-%,
wherein further the xylene cold solubles (XCS) of the polypropylene composition has an amount of (a) of ethylene-derived comonomer units of from 20.0 to 80.0 mol-%; and/or (b) of C5-12 α-olefin-derived comonomer units of from 0.1 to 1.5 mol-%.
4. The polypropylene composition according to claim 3, wherein the polypropylene composition fulfills in-equation (I)
IV(XCS)−IV(tot)≦0.30 (I)
IV(XCS)−IV(tot)≦0.30 (I)
wherein
IV(XCS) is the intrinsic viscosity (IV) of the xylene cold soluble (XCS) fraction of the polypropylene composition and IV(tot) is the intrinsic viscosity (IV) of the polypropylene composition.
5. The polypropylene composition according to claim 1, wherein
(a) the amount of 20 wt-% of ethylene-derived comonomer units in the xylene cold soluble (XCS) fraction of the polypropylene composition is excluded; and/or
(b) the polypropylene composition fulfills in-equation (II)
wherein
CX(XCS) is the amount in mol-% of C5-12 α-olefin-derived comonomer units in the xylene cold soluble (XCS) fraction of the polypropylene composition,
XCS is the amount in wt.-% of xylene cold soluble (XCS) fraction of the polypropylene composition.
6. The polypropylene composition according to claim 1, wherein
(a) the C5-12 α-olefin is 1-hexene or 1-octene; and/or
(b) the total amount of comonomer units in the polypropylene composition is from 9.4 to 55.5 mol-%.
7. The polypropylene composition according to claim 1, wherein
(a) the intrinsic viscosity (IV) of the xylene cold soluble (XCS) fraction of the polypropylene composition is in the range of 1.5 to 4.0 dl/g; and/or
(b) the intrinsic viscosity (IV) of the polypropylene composition is in the range of 1.0 to 3.0 dl/g.
8. The polypropylene composition according to claim 1, wherein the polypropylene composition has a glass transition temperature below −25° C.
9. The polypropylene composition according to claim 1, wherein the propylene copolymer (C) comprises a propylene homopolymer fraction (HF1) and a propylene copolymer fraction (CF1′), wherein further the propylene copolymer fraction (CF1′) consists of units derived from derived from propylene and at least one C5-12 α-olefin.
10. The polypropylene composition according to claim 1, wherein
(a) the terpolymer (T) has a comonomer content in the range of 20.05 to 82.0 mol-%; and/or
(b) the weight ratio between the propylene homopolymer fraction (HF1) and the propylene copolymer fraction (CF1′) [(HF1)/(CF1′)] is 75/25 to 30/70; and/or
(c) the weight ratio between the propylene copolymer (C) and the elastomeric copolymer (E) [(C)/(E)] is 75/25 to 40/60.
11. A molded article comprising the polypropylene composition according to claim 1.
12. A process for preparing the polypropylene composition according to claim 1, comprising
(i) preparing the propylene homopolymer fraction (HF1) in a first polymerization reactor PR1,
(ii) transferring the propylene homopolymer fraction (HF1) obtained in the polymerization reactor (R1) to a polymerization reactor (R2) and preparing the propylene copolymer fraction (CF1′) by polymerizing propylene and at least one C5-12 α-olefin in the presence of propylene homopolymer fraction (HF1), thereby obtaining the propylene copolymer (C); and
(iii) transferring the propylene copolymer (C) of step (ii) into a polymerization reactor (R3) and preparing the elastomeric copolymer (E) by polymerizing propylene, ethylene and at least one C5-12 α-olefin in the presence of the propylene copolymer (C), thereby obtaining the polypropylene composition.
13. The polypropylene composition according to claim 6, wherein
(a) the C5-12 α-olefin is 1-hexene; and/or
(b) the total amount of comonomer units are derived from ethylene and at least one C5-12 α-olefin in the polypropylene composition is from 9.4 to 55.5 mol-%.
14. The polypropylene composition according to claim 3, wherein
(a) the amount of 20 wt-% of ethylene-derived comonomer units in the xylene cold soluble (XCS) fraction of the polypropylene composition is excluded; and/or
(b) the polypropylene composition fulfills in-equation (II)
wherein
CX(XCS) is the amount in mol-% of C5-12 α-olefin-derived comonomer units in the xylene cold soluble (XCS) fraction of the polypropylene composition,
XCS is the amount in wt.-% of xylene cold soluble (XCS) fraction of the polypropylene composition.
15. The polypropylene composition according to claim 3, wherein
(a) the C5-12 α-olefin is 1-hexene or 1-octene; and/or
(b) the total amount of comonomer units in the polypropylene composition is from 9.4 to 55.5 mol-%.
16. The polypropylene composition according to claim 3, wherein
(a) the intrinsic viscosity (IV) of the xylene cold soluble (XCS) fraction of the polypropylene composition is in the range of 1.5 to 4.0 dl/g; and/or
(b) the intrinsic viscosity (IV) of the polypropylene composition is in the range of 1.0 to 3.0 dl/g.
17. The polypropylene composition according to claim 3, wherein the polypropylene composition has a glass transition temperature below −25° C.
18. The polypropylene composition according to claim 3, wherein the polypropylene composition is a heterophasic propylene copolymer (HECO) comprising a propylene copolymer (C) and an elastomeric copolymer (E), wherein the propylene copolymer (C) is a propylene copolymer of units derived from propylene and at least one C5-12 α-olefin and the elastomeric copolymer (E) is a terpolymer (T) of units derived from propylene, ethylene and C5-12 α-olefin.
19. The polypropylene composition according to claim 18, wherein the propylene copolymer (C) comprises a propylene homopolymer fraction (HF1) and a propylene copolymer fraction (CF1′), wherein further the propylene copolymer fraction (CF1′) consists of units derived from derived from propylene and at least one C5-12 α-olefin.
Patent Citations (294)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| US4107414(A) | 1978-08-01 | Giannini et al. | Applicant |
| US4186107(A) | 1980-01-01 | Wagner | Applicant |
| US4226963(A) | 1980-10-01 | Giannini et al. | Applicant |
| US4347160(A) | 1982-08-01 | Epstein et al. | Applicant |
| US4382019(A) | 1983-05-01 | Greco | Applicant |
| US4435550(A) | 1984-03-01 | Ueno et al. | Applicant |
| US4465782(A) | 1984-08-01 | McKenzie | Applicant |
| US4472524(A) | 1984-09-01 | Albizzati | Applicant |
| US4473660(A) | 1984-09-01 | Albizzati et al. | Applicant |
| US4522930(A) | 1985-06-01 | Albizzati et al. | Applicant |
| US4530912(A) | 1985-07-01 | Pullukat et al. | Applicant |
| US4532313(A) | 1985-07-01 | Matlack | Applicant |
| US4560671(A) | 1985-12-01 | Gross et al. | Applicant |
| US4581342(A) | 1986-04-01 | Johnson et al. | Applicant |
| US4657882(A) | 1987-04-01 | Karayannis et al. | Applicant |
| US4665208(A) | 1987-05-01 | Welborn, Jr. et al. | Applicant |
| US4874734(A) | 1989-10-01 | Kioka et al. | Applicant |
| US4908463(A) | 1990-03-01 | Bottelberghe | Applicant |
| US4924018(A) | 1990-05-01 | Bottelberghe | Applicant |
| US4952540(A) | 1990-08-01 | Kioka et al. | Applicant |
| US4968827(A) | 1990-11-01 | Davis | Applicant |
| US5091352(A) | 1992-02-01 | Kioka et al. | Applicant |
| US5103031(A) | 1992-04-01 | Smith, Jr. | Applicant |
| US5157137(A) | 1992-10-01 | Sangokoya | Applicant |
| US5204419(A) | 1993-04-01 | Tsutsui et al. | Applicant |
| US5206199(A) | 1993-04-01 | Kioka et al. | Applicant |
| US5235081(A) | 1993-08-01 | Sangokoya | Applicant |
| US5248801(A) | 1993-09-01 | Sangokoya | Applicant |
| US5308815(A) | 1994-05-01 | Sangokoya | Applicant |
| US5329032(A) | 1994-07-01 | Tran et al. | Applicant |
| US5391529(A) | 1995-02-01 | Sangokoya | Applicant |
| US5391793(A) | 1995-02-01 | Marks et al. | Applicant |
| US5504172(A) | 1996-04-01 | Imuta et al. | Applicant |
| US5529850(A) | 1996-06-01 | Morini et al. | Applicant |
| US5539067(A) | 1996-07-01 | Parodi et al. | Applicant |
| US5618771(A) | 1997-04-01 | Parodi et al. | Applicant |
| US5691043(A) | 1997-11-01 | Keller et al. | Applicant |
| US5693838(A) | 1997-12-01 | Sangokoya et al. | Applicant |
| US5731253(A) | 1998-03-01 | Sangokoya | Applicant |
| US5731451(A) | 1998-03-01 | Smith et al. | Applicant |
| US5744656(A) | 1998-04-01 | Askham | Applicant |
| US6316562(B1) | 2001-11-01 | Munck et al. | Applicant |
| US6322883(B1) | 2001-11-01 | Williams | Applicant |
| US6586528(B1) | 2003-07-01 | Delaite et al. | Applicant |
| US6642317(B1) | 2003-11-01 | Delaite et al. | Applicant |
| US7342078(B2) | 2008-03-01 | Schottek et al. | Applicant |
| US7378472(B2) | 2008-05-01 | Fell et al. | Applicant |
| US7569651(B2) | 2009-08-01 | Schottek et al. | Applicant |
| US8709561(B2) | 2014-04-01 | Bernreitner et al. | Applicant |
| US8779062(B2) | 2014-07-01 | Paavilainen et al. | Applicant |
| US8889792(B2) | 2014-11-01 | Paavilainen et al. | Applicant |
| US9243137(B2) | 2016-01-01 | Reichelt et al. | Applicant |
| US2003/0149199(A1) | 2003-08-01 | Schottek et al. | Applicant |
| US2004/0033349(A1) | 2004-02-01 | Henderson | Applicant |
| US2005/0136274(A1) | 2005-06-01 | Hamulski et al. | Applicant |
| US2005/0187367(A1) | 2005-08-01 | Hori et al. | Applicant |
| US2005/0200046(A1) | 2005-09-01 | Breese | Applicant |
| US2006/0020096(A1) | 2006-01-01 | Schottek et al. | Applicant |
| US2006/0155080(A1) | 2006-07-01 | Fell et al. | Applicant |
| US2006/0182987(A1) | 2006-08-01 | Yu et al. | Applicant |
| US2006/0211801(A1) | 2006-09-01 | Miller et al. | Applicant |
| US2007/0235896(A1) | 2007-10-01 | McLeod et al. | Applicant |
| US2008/0214767(A1) | 2008-09-01 | Mehta et al. | Applicant |
| US2010/0029883(A1) | 2010-02-01 | Krajete et al. | Applicant |
| US2010/0081760(A1) | 2010-04-01 | Rhee et al. | Applicant |
| US2010/0099824(A1) | 2010-04-01 | Helland et al. | Applicant |
| US2010/0304062(A1) | 2010-12-01 | Daviknes et al. | Applicant |
| US2011/0031645(A1) | 2011-02-01 | Kuettel et al. | Applicant |
| US2012/0189830(A1) | 2012-07-01 | Niepelt et al. | Applicant |
| US2012/0220727(A1) | 2012-08-01 | Klimke et al. | Examiner |
| US2013/0045862(A1) | 2013-02-01 | Valonen et al. | Applicant |
| US2013/0167486(A1) | 2013-07-01 | Aarnio et al. | Applicant |
| US2013/0178573(A1) | 2013-07-01 | Paavilainen et al. | Applicant |
| US2013/0203931(A1) | 2013-08-01 | Paavilainen et al. | Applicant |
| US2013/0236668(A1) | 2013-09-01 | Bernreitner et al. | Applicant |
| US2014/0005324(A1) | 2014-01-01 | Reichelt et al. | Applicant |
| US2016/0185946(A1) | 2016-06-01 | Sandholzer et al. | Applicant |
| US2016/0194486(A1) | 2016-07-01 | Sandholzer et al. | Applicant |
| US2016/0200838(A1) | 2016-07-01 | Reznichenko et al. | Applicant |
| US2016/0208085(A1) | 2016-07-01 | Gloger et al. | Applicant |
| US2016/0229158(A1) | 2016-08-01 | Cavacas et al. | Applicant |
| US2016/0237270(A1) | 2016-08-01 | Wang et al. | Applicant |
| US2016/0244539(A1) | 2016-08-01 | Resconi et al. | Applicant |
| US2016/0272740(A1) | 2016-09-01 | Wang et al. | Applicant |
| US2016/0304681(A1) | 2016-10-01 | Potter et al. | Applicant |
| US2016/0311951(A1) | 2016-10-01 | Reichelt et al. | Applicant |
| US2016/0311988(A1) | 2016-10-01 | Potter et al. | Applicant |
| US2016/0312018(A1) | 2016-10-01 | Vestberg et al. | Applicant |
| US2016/0312019(A1) | 2016-10-01 | Lampela et al. | Applicant |
| CN101563226(A) | 1997-11-01 | Applicant | |
| CN1248198(A) | 2000-03-01 | Applicant | |
| CN1398272(A) | 2003-02-01 | Applicant | |
| CN1823106(A) | 2006-08-01 | Applicant | |
| CN102869719(A) | 2013-01-01 | Applicant | |
| CN103068574(A) | 2013-04-01 | Applicant | |
| CN103347951(A) | 2013-10-01 | Applicant | |
| EP45977(B1) | 1987-01-01 | Applicant | |
| EP260130(A1) | 1988-03-01 | Applicant | |
| EP279586(A2) | 1988-08-01 | Applicant | |
| EP45975(B1) | 1989-04-01 | Applicant | |
| EP45976(B1) | 1989-11-01 | Applicant | |
| EP361493(A1) | 1990-04-01 | Applicant | |
| EP423101(A2) | 1991-04-01 | Applicant | |
| EP488595(A1) | 1992-06-01 | Applicant | |
| EP491566(A2) | 1992-06-01 | Applicant | |
| EP537130(A1) | 1993-04-01 | Applicant | |
| EP561476(A1) | 1993-09-01 | Applicant | |
| EP45976(B2) | 1993-12-01 | Applicant | |
| EP594218(A1) | 1994-04-01 | Applicant | |
| EP279586(B1) | 1994-05-01 | Applicant | |
| EP622380(A1) | 1994-11-01 | Applicant | |
| EP45977(B2) | 1995-03-01 | Applicant | |
| EP645417(A1) | 1995-03-01 | Applicant | |
| EP728769(A1) | 1996-08-01 | Applicant | |
| EP586390(B1) | 1997-05-01 | Applicant | |
| EP591224(B1) | 1998-02-01 | Applicant | |
| EP887379(A1) | 1998-12-01 | Applicant | |
| EP887380(A1) | 1998-12-01 | Applicant | |
| EP887381(A1) | 1998-12-01 | Applicant | |
| EP1028984(B1) | 2001-07-01 | Applicant | |
| EP1359171(A1) | 2003-11-01 | Applicant | |
| EP1376516(A1) | 2004-01-01 | Applicant | |
| EP1452630(A1) | 2004-09-01 | Applicant | |
| EP1183307(B1) | 2005-07-01 | Applicant | |
| EP991684(B1) | 2006-01-01 | Applicant | |
| EP1632529(A1) | 2006-03-01 | Applicant | |
| EP1448622(B1) | 2006-04-01 | Applicant | |
| EP1726602(A1) | 2006-11-01 | Applicant | |
| EP1741725(A1) | 2007-01-01 | Applicant | |
| EP1788023(A1) | 2007-05-01 | Applicant | |
| EP1883080(A1) | 2008-01-01 | Applicant | |
| EP1892264(A1) | 2008-02-01 | Applicant | |
| EP1923200(A1) | 2008-05-01 | Applicant | |
| EP1941997(A1) | 2008-07-01 | Applicant | |
| EP1941998(A1) | 2008-07-01 | Applicant | |
| EP1947143(A1) | 2008-07-01 | Applicant | |
| EP1990353(A1) | 2008-11-01 | Applicant | |
| EP2014714(A1) | 2009-01-01 | Applicant | |
| EP2062936(A1) | 2009-05-01 | Applicant | |
| EP2065087(A1) | 2009-06-01 | Applicant | |
| EP2075284(A1) | 2009-07-01 | Applicant | |
| EP2174980(A1) | 2010-04-01 | Applicant | |
| EP2251361(A1) | 2010-11-01 | Applicant | |
| EP2386582(A1) | 2011-11-01 | Applicant | |
| EP2386583(A1) | 2011-11-01 | Applicant | |
| EP2386602(A1) | 2011-11-01 | Applicant | |
| EP2386604(A1) | 2011-11-01 | Applicant | |
| EP2038346(B1) | 2012-01-01 | Applicant | |
| EP2410007(A1) | 2012-01-01 | Applicant | |
| EP2415831(A1) | 2012-02-01 | Applicant | |
| EP2423257(A1) | 2012-02-01 | Applicant | |
| EP1358252(B1) | 2012-04-01 | Applicant | |
| EP2308923(B1) | 2012-05-01 | Applicant | |
| EP2487203(A1) | 2012-08-01 | Applicant | |
| EP2532687(A2) | 2012-12-01 | Applicant | |
| EP2546298(A1) | 2013-01-01 | Applicant | |
| EP2551299(A1) | 2013-01-01 | Applicant | |
| EP2565221(A1) | 2013-03-01 | Applicant | |
| EP2573134(A1) | 2013-03-01 | Applicant | |
| EP2592112(A1) | 2013-05-01 | Applicant | |
| EP2610270(A1) | 2013-07-01 | Applicant | |
| EP2610271(A1) | 2013-07-01 | Applicant | |
| EP2610272(A1) | 2013-07-01 | Applicant | |
| EP2610273(A1) | 2013-07-01 | Applicant | |
| EP2666818(A1) | 2013-11-01 | Applicant | |
| JP2003-522259(A) | 2003-07-01 | Applicant | |
| JP2007-526345(A) | 2007-09-01 | Applicant | |
| JP2013-525531(A) | 2013-06-01 | Applicant | |
| JP2013-525532(A) | 2013-06-01 | Applicant | |
| WO87/07620(A1) | 1987-12-01 | Applicant | |
| WO92/12182(A1) | 1992-07-01 | Applicant | |
| WO92/13029(A1) | 1992-08-01 | Applicant | |
| WO92/19653(A1) | 1992-11-01 | Applicant | |
| WO92/19658(A1) | 1992-11-01 | Applicant | |
| WO92/19659(A1) | 1992-11-01 | Applicant | |
| WO92/21705(A1) | 1992-12-01 | Applicant | |
| WO93/11165(A1) | 1993-06-01 | Applicant | |
| WO93/11166(A1) | 1993-06-01 | Applicant | |
| WO93/19100(A1) | 1993-09-01 | Applicant | |
| WO94/10180(A1) | 1994-05-01 | Applicant | |
| WO94/14856(A1) | 1994-07-01 | Applicant | |
| WO95/12622(A1) | 1995-05-01 | Applicant | |
| WO95/32994(A1) | 1995-12-01 | Applicant | |
| WO97/10248(A1) | 1997-03-01 | Applicant | |
| WO97/14700(A1) | 1997-04-01 | Applicant | |
| WO97/28170(A1) | 1997-08-01 | Applicant | |
| WO97/36939(A1) | 1997-10-01 | Applicant | |
| WO98/12234(A1) | 1998-03-01 | Applicant | |
| WO98/16359(A1) | 1998-04-01 | Applicant | |
| WO98/38041(A1) | 1998-09-01 | Applicant | |
| WO98/40331(A1) | 1998-09-01 | Applicant | |
| WO98/46616(A1) | 1998-10-01 | Applicant | |
| WO98/47929(A1) | 1998-10-01 | Applicant | |
| WO98/49208(A1) | 1998-11-01 | Applicant | |
| WO98/56831(A1) | 1998-12-01 | Applicant | |
| WO98/58971(A1) | 1998-12-01 | Applicant | |
| WO98/58976(A1) | 1998-12-01 | Applicant | |
| WO98/58977(A1) | 1998-12-01 | Applicant | |
| WO99/10353(A1) | 1999-03-01 | Applicant | |
| WO99/12981(A1) | 1999-03-01 | Applicant | |
| WO99/19335(A1) | 1999-04-01 | Applicant | |
| WO99/24478(A1) | 1999-05-01 | Applicant | |
| WO99/24479(A1) | 1999-05-01 | Applicant | |
| WO99/33842(A1) | 1999-07-01 | Applicant | |
| WO99/41290(A1) | 1999-08-01 | Applicant | |
| WO/34341(A2) | 2000-06-01 | Applicant | |
| WO/68315(A1) | 2000-11-01 | Applicant | |
| WO1/48034(A2) | 2001-07-01 | Applicant | |
| WO1/58970(A1) | 2001-08-01 | Applicant | |
| WO1/70395(A2) | 2001-09-01 | Applicant | |
| WO2/02576(A1) | 2002-01-01 | Applicant | |
| WO2/051912(A1) | 2002-07-01 | Applicant | |
| WO2/057342(A2) | 2002-07-01 | Applicant | |
| WO3/000754(A1) | 2003-01-01 | Applicant | |
| WO3/000755(A2) | 2003-01-01 | Applicant | |
| WO3/000756(A2) | 2003-01-01 | Applicant | |
| WO3/000757(A1) | 2003-01-01 | Applicant | |
| WO3/051934(A2) | 2003-06-01 | Applicant | |
| WO3/054035(A1) | 2003-07-01 | Applicant | |
| WO3/066698(A1) | 2003-08-01 | Applicant | |
| WO3/082879(A1) | 2003-10-01 | Applicant | |
| WO4/000899(A1) | 2003-12-01 | Applicant | |
| WO2004/013193(A2) | 2004-02-01 | Applicant | |
| WO2004/029112(A1) | 2004-04-01 | Applicant | |
| WO2004/111095(A1) | 2004-12-01 | Applicant | |
| WO2005/066247(A1) | 2005-07-01 | Applicant | |
| WO2005/105863(A2) | 2005-11-01 | Applicant | |
| WO2006/069733(A1) | 2006-07-01 | Applicant | |
| WO2006/086134(A1) | 2006-08-01 | Applicant | |
| WO2006/097497(A1) | 2006-09-01 | Applicant | |
| WO2007/077027(A1) | 2007-07-01 | Applicant | |
| WO2007/107448(A1) | 2007-09-01 | Applicant | |
| WO2007/116034(A1) | 2007-10-01 | Applicant | |
| WO2007/122239(A1) | 2007-11-01 | Applicant | |
| WO2007/137853(A1) | 2007-12-01 | Applicant | |
| WO2008/034630(A1) | 2008-03-01 | Applicant | |
| WO2008/074713(A1) | 2008-06-01 | Applicant | |
| WO2008/132035(A1) | 2008-11-01 | Applicant | |
| WO2009/019169(A1) | 2009-02-01 | Applicant | |
| WO2009/027075(A2) | 2009-03-01 | Applicant | |
| WO2009/054832(A1) | 2009-04-01 | Applicant | |
| WO2009/063819(A1) | 2009-05-01 | Applicant | |
| WO2009/077287(A1) | 2009-06-01 | Applicant | |
| WO2009/092691(A1) | 2009-07-01 | Applicant | |
| WO2010/009827(A1) | 2010-01-01 | Applicant | |
| WO2010/039715(A1) | 2010-04-01 | Applicant | |
| WO2010/052260(A1) | 2010-05-01 | Applicant | |
| WO2010/052263(A1) | 2010-05-01 | Applicant | |
| WO2010/053644(A1) | 2010-05-01 | Applicant | |
| WO2010/082943(A1) | 2010-07-01 | Applicant | |
| WO2010/115878(A1) | 2010-10-01 | Applicant | |
| WO2010/142540(A1) | 2010-12-01 | Applicant | |
| WO2011/023594(A1) | 2011-03-01 | Applicant | |
| WO2011/039305(A1) | 2011-04-01 | Applicant | |
| WO2011/117032(A1) | 2011-09-01 | Applicant | |
| WO2011/135004(A2) | 2011-11-01 | Applicant | |
| WO2011/135005(A2) | 2011-11-01 | Applicant | |
| WO2011/138211(A1) | 2011-11-01 | Applicant | |
| WO2011/141380(A1) | 2011-11-01 | Applicant | |
| WO2011/144703(A1) | 2011-11-01 | Applicant | |
| WO2011/160936(A1) | 2011-12-01 | Applicant | |
| WO2012/001052(A2) | 2012-01-01 | Applicant | |
| WO2012/007430(A1) | 2012-01-01 | Applicant | |
| WO2012/093098(A1) | 2012-07-01 | Applicant | |
| WO2013/004507(A1) | 2013-01-01 | Applicant | |
| WO2013/007650(A1) | 2013-01-01 | Applicant | |
| WO2013/010879(A1) | 2013-01-01 | Applicant | |
| WO2013/050119(A1) | 2013-04-01 | Applicant | |
| WO2013/092615(A1) | 2013-06-01 | Applicant | |
| WO2013/092620(A1) | 2013-06-01 | Applicant | |
| WO2013/092624(A1) | 2013-06-01 | Applicant | |
| WO2013/127707(A1) | 2013-09-01 | Applicant | |
| WO2014/023603(A1) | 2014-02-01 | Applicant | |
| WO2014/023604(A1) | 2014-02-01 | Applicant | |
| WO2015/022127(A1) | 2015-02-01 | Applicant | |
| WO2015/024887(A1) | 2015-02-01 | Applicant | |
| WO2015/024891(A1) | 2015-02-01 | Applicant | |
| WO2015/044116(A1) | 2015-04-01 | Applicant | |
| WO2015/052246(A1) | 2015-04-01 | Applicant | |
| WO2015/059229(A1) | 2015-04-01 | Applicant | |
| WO2015/059230(A1) | 2015-04-01 | Applicant | |
| WO2015/062936(A1) | 2015-05-01 | Applicant | |
| WO2015/075088(A1) | 2015-05-01 | Applicant | |
| WO2015/082379(A1) | 2015-06-01 | Applicant | |
| WO2015/091660(A1) | 2015-06-01 | Applicant | |
| WO2015/091829(A1) | 2015-06-01 | Applicant | |
| WO2015/091839(A1) | 2015-06-01 | Applicant | |
| WO2015/101593(A1) | 2015-07-01 | Applicant | |
| WO2015/107020(A1) | 2015-07-01 | Applicant | |
| WO2015/113907(A1) | 2015-08-01 | Applicant | |
| WO2015/117948(A1) | 2015-08-01 | Applicant | |
| WO2015/117958(A1) | 2015-08-01 | Applicant | |
| WO2015/121160(A1) | 2015-08-01 | Applicant | |
| WO2015/177094(A1) | 2015-11-01 | Applicant |
Non-Patent Literature (63)
- U.S. Appl. No. 14/911,295, filed Feb. 10, 2016.Applicant
- U.S. Appl. No. 14/911,300, filed Feb. 10, 2016.Applicant
- U.S. Appl. No. 14/914,501, filed Feb. 25, 2016.Applicant
- U.S. Appl. No. 15/022,664, filed Mar. 17, 2016.Applicant
- U.S. Appl. No. 15/022,671, filed Mar. 17, 2016.Applicant
- U.S. Appl. No. 15/027,129, filed Apr. 4, 2016.Applicant
- U.S. Appl. No. 15/029,493, filed Apr. 14, 2016.Applicant
- U.S. Appl. No. 15/030,556, filed Apr. 19, 2016.Applicant
- U.S. Appl. No. 15/039,107, filed May 25, 2016.Applicant
- U.S. Appl. No. 15/101,837, filed Jun. 3, 2016.Applicant
- U.S. Appl. No. 15/102,628, filed Jun. 8, 2016.Applicant
- U.S. Appl. No. 15/103,744, filed Jun. 10, 2016.Applicant
- U.S. Appl. No. 15/103,783, filed Jun. 10, 2016.Applicant
- U.S. Appl. No. 15/106,101, filed Jun. 17, 2016.Applicant
- U.S. Appl. No. 15/113,517, filed Jul. 22, 2016.Applicant
- U.S. Appl. No. 15/113,907, filed Jul. 25, 2016.Applicant
- U.S. Appl. No. 15/113,922, filed Jul. 25, 2016.Applicant
- U.S. Appl. No. 15/115,929, filed Aug. 2, 2016.Applicant
- “Glossary of Basic Terms in Polymer Science (IUPAC Recommendations 1996),” Pure Appl. Chem., 68(8):1591-1595 (1996).Applicant
- “MDO Film—Oriented PE and PP packaging film,” IN0128/GB FF 2004 10, Borealis A/S (2004).Applicant
- Abiru et al., “Microstructural Characterization of Propylene-Butene-1 Copolymer Using Temperature Rising elution Fractionation,” J. Appl. Polymer Sci 68:1493-1501 (1998).Applicant
- Atwood, “Chapter 6: Anionic and Cationic Organoaluminum Compounds,” Coord. Chem. Alum., VCH, New York, NY, pp. 197-232 (1993).Applicant
- Britovsek el al., “The Search for New-Generation Olefin Polymerization Catalysts: Life beyond Metallocenes,” Angew. Chem. Int. Ed., vol. 38(4), pp. 428-447 (1999).Applicant
- Busico et al., “Alk-1-ene Polymerization in the Presence of a Monocyclopentadienyl Zirconium(IV) Acetamidinate Catalyst: Microstructural and Mechanistic Insightsa ,” Macromol. Rapid Commun. 28:1128-1134 (2007).Applicant
- Busico et al., “Full Assignment of the 13C NMR Spectra of Regioregular Polypropylenes: Methyl and Methylene Region,” Macromolecules 30:6251-6263 (1997).Applicant
- Busico et al., “Microstructure of polypropylene,” Prog. Polym. Sci. 26:443-533 (2001).Applicant
- Castignolles et al., “Detection and quantification of branching in polyacrylates by size-exclusion chromatography (SEC) and melt-state 13C NMR spectroscopy,” Polymer, 50(11):2373-2383, (2009).Applicant
- Cheng, “13C NMR Analysis of Ethylene-Propylene Rubbers,” Macromolecules 17:1950-1955 (1984).Applicant
- Cimmino et al., “Thermal and mechanical properties of isotactic random propylene-butene-1 copolymers,” Polymer 19:1222-1223 (1978).Applicant
- Crispino et al., “Influence of Composition on the Melt Crystallization of Isotactic Random Propylene/1-Butene Copolymers,” Makromol. Chem. 181:1747-1755 (1980).Applicant
- Filip et al., “Heteronuclear decoupling under fast MAS by a rotor-synchronized Hahn-echo pulse train,”J. Magnet. Reson. 176:239-243 (2005).Applicant
- Fujiyama et al., “Effect of Molecular Parameters on the Shrinkage of Injection-Molded Polypropylene,” J. Appl. Polym. Sci. 22:1225-1241 (1978).Applicant
- Gahleitner et al., “Nucleation of Polypropylene Homo- and Copolymers,” International Polymer Processing 26(1):2-20 (2011).Applicant
- Galli et al., “Technology: driving force behind innovation and growth of polyolefins,” Prog. Polym. Sci. 26:1287-1336 (2001).Applicant
- Grein et al., “Impact Modified Isotatic Polypropylene with Controlled Rubber Intrinsic Viscosities: Some New Aspects About Morphology and Fracture,” J. Appl. Polymer Sci., 87:1702-1712 (2003).Applicant
- Griffin et al., “Low-load rotor-synchronised Hahn-echo pulse train (RS-HEPT) 1 H decoupling in solid-state NMR: factors affecting MAS spin-echo dephasing times,” Magn. Reson. Chem. 45:S198-S208 (2007).Applicant
- Holbrey et al., “Liquid clathrate formation in ionic liquid-aromatic mixtures,” Chem. Comm., 2003, pp. 476-477.Applicant
- Kakugo et al., “13C NMR Determination of Monomer Sequence Distribution in Ethylene-Propylene Copolymers Prepared with δ-TiCl3-Al(C2H5)2Cl,” Macromolecules 15:1150-1152 (1982).Applicant
- Klimke et al., “Optimisation and Application of Polyolefin Branch Quantification by Melt-State 13C NMR Spectroscopy,” Macromol. Chem. Phys. 207(4):382-395 (2006).Applicant
- McAuley et al., “On-line Inference of Polymer Properties in an Industrial Polyethylene Reactor,” AlChE Journal, vol. 37, No. 6, pp. 825-835 (1991).Applicant
- Myhre et al., “Oriented PE films—Expanding Opportunities with Borstar® PE,” Maack Speciality Films, pp. 1-10 (2001).Applicant
- Parkinson et al., “Effect of Branch Length on 13C NMR Relaxation Properties in Molten Poly[ethylene-co-(α-olefin)] Model Systems,” Macromol. Chem. Phys. 208(19-20):2128-2133 (2007).Applicant
- Plastics Additives Handbook, 5th edition, Hans Zweifel, Editor, Hanser Publishers, Munich, pp. 871-873 (2001).Applicant
- Plastics Additives Handbook, 5th edition, Hans Zweifel, Editor, Hanser Publishers, Munich, pp. 956-965 (2001).Applicant
- Pollard et al., “Observation of Chain Branching in Polyethylene in the Solid State and Melt via 13C NMR Spectroscopy and Melt NMR Relaxation Time Measurements,” Macromolecules, 37(3):813-825 (2004).Applicant
- Propylene Handbook, 2ndEdition Chapter 7.2.2 “Oriented Films,” pp. 405-415, Nello Pasquini, Editor, Hanser (2005).Applicant
- Randall, “A Review of High Resolution Liquid 13Carbon Nuclear Magnetic Resonance Characterizations of Ethylene-Based Polymers,” JMS-Rev. Macromol. Chem. Phys., C29(2 & 3):201-317 (1989).Applicant
- Resconi et al., “Diastereoselective Synthesis, Molecular Structure, and Solution Dynamics of meso- and rac-[Ethylenebis(4,7-dimethyl-η5-1-indenyl)]zirconium Dichloride Isomers and Chain Transfer Reactions in Propene Polymerization with the rac Isomer,” Organometallics 15(23):5046-5059 (1996).Applicant
- Resconi et al., “Highly Regiospecific Zirconocene Catalysts for the Isospecific Polymerization of Propene,” JACS 120(10):2308-2321 (1998).Applicant
- Resconi et al., “Selectivity in Propene Polymerization with Metallocene Catalysts,” Chem. Rev. 100(4):1253-1345 (2000).Applicant
- Singh et al., “Triad sequence determination of ethylene-propylene copolymers—application of quantitative 13 C NMR,” Polymer Testing 28(5):475-479 (2009).Applicant
- Spaleck et al., “The Influence of Aromatic Substituents on the Polymerization Behavior of Bridged Zirconocene Catalysts,” Organometallics 13:954-963 (1994).Applicant
- Spear et al., “Liquid Clathrates,” Encyclopedia of Supramolecular Chemistry, J.L. Atwood and J.W. Steed (Eds.); Marcel Dekker: New York, pp. 804-808 (2004).Applicant
- Wang et al., “Structural Analysis of Ethylene/Propylene Copolymers Synthesized with a Constrained Geometry Catalyst,” Macromolecules 33:1157-1162 (2000).Applicant
- Zhou et al., “A new decoupling method for accurate quantification of polyethylene copolymer composition and triad sequence distribution with 13C NMR,” J. Magnet. Reson. 187:225-233 (2007).Applicant
- European Patent Office, International Search Report in International Application No. PCT/EP2014/065010 (Aug. 1, 2014).Applicant
- European Patent Office, Written Opinion in International Application No. PCT/EP2014/065010 (Aug. 1, 2014).Applicant
- European Patent Office, International Preliminary Report on Patentability in International Application No. PCT/EP2014/065010 (Feb. 25, 2016).Applicant
- Koch et al., “Evaluation of scratch resistance in multiphase PP blends,” Polymer Testing 26: 927-936 (2007).Applicant
- “Polyethylene Lumicene® mPE M5510 EP,” Total Refining & Chemicals, Total Ecosolutions, Belgium, Aug. 2013 (2 pgs.).Applicant
- State Intellectual Property Office of the People's Republic of China, First Notification of Office Action in Chinese Patent Application No. 201480045175.2 (Nov. 2, 2016).Applicant
- Korean Intellectual Propety Office, Notice of Grounds for Rejection in Korean Patent Application No. 10-2016-7005781 (Feb. 15, 2017).Applicant
- Japanese Patent Office, Notice of Reasons for Rejection in Japanese Patent Application No. 2016-533853 (Mar. 14, 2017).Applicant